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        Vps4 is an AAA ATPase that functions in the ESCRT-mediated membrane 
fission process. Vps4 can use the energy from ATP hydrolysis to disassemble 
the ESCRT-III complexes. However, the mechanism of ESCRT-III disassembly 
by Vps4 is not clear. I have tried to address two major questions of Vps4 
mechanism: how do monomers form the functional oligomer, and how does the 
functional Vps4 oligomer process its substrate ESCRT-III proteins. In Chapter 2, 
which was published recently, we reported that the functional state of Vps4 is a 
hexamer, and that the interface mediating hexamer formation has been 
conserved in highly diverse species. Chapter 3 describes my attempts to 
crystallize an assembled Vps4 hexamer. Despite considerable effort, I was not 
successful in obtaining crystals of assembled Vps4 that diffract to high resolution, 
although some preliminary crystals that appear to contain a complex of Vps4 
hexamer and the substrate peptide were obtained and may serve as a guide for 
future efforts. In Chapter 4, I report that residues in helix5 of the Vps2/ESCRT-III 
protein form a secondary Vps4 binding site, and show that they bind to the pore 
loops of an asymmetric Vps4 hexamer in a 1:1 peptide:Vps4 hexamer 
stoichiometry. I further demonstrate that this interaction is negatively regulated by 
the N-terminal MIT domain of Vps4.  These findings support a model of ESCRT-
III disassembly in which the Vps4 hexamer pulls the C-terminal helix5 of ESCRT-
iv 
 
III into/through the central pore of the asymmetric Vps4 hexamer. In Chapter 5, I 
suggest future experiments that could be pursued to confirm this model and 
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Overview of the ESCRT machinery 
        The endosomal sorting complexes required for transport (ESCRT) 
machinery was first identified in the multivesicular bodies (MVBs) biogenesis 
process1; 2; 3; 4; 5. Later, the ESCRT machinery was found to be required for other 
biological processes, such as HIV-1 budding6; 7; 8; 9, mammalian cytokinesis10; 11, 
and cell division in Crenarchaeal species12; 13 (Figure 1.1 A). All of these 
processes entail membrane fission of the same topology14. Proteins that drive 
membrane fission reside within the thin membrane necks before membrane 
fission finishes 14(Figure 1.1 B, left). This is in contrast to the topology of clathrin-
mediated endocytosis, in which dynamin mediates membrane fission from the 
outside face of the thin membrane tubes15 (Figure 1.1 B, right). Different 
proteins/protein complexes of ESCRT machinery function sequentially. Early 
acting complexes are responsible for cargo sorting, recruiting late acting 
proteins/complexes, and/or membrane deformation14. Late acting 
proteins/complexes are responsible for membrane fission14. In this chapter I will 
summarize how the ESCRT machinery functions in different biological processes, 







Figure 1.1 ESCRT mediated membrane fission. 
A: Different biological processes require the ESCRT machinery for membrane 
fission. 
B: Two different topologies of membrane fission. Left: ESCRT-III mediated 
membrane fission. ESCRT-III resides on the inside face of the thin tube during 
membrane fission for events that bud away from the cytosol. Right: Dynamin 
mediated membrane fission. Dynamin resides on the outside face of the thin tube 
for events that bud into the cytosol. 
 
 
exosome budding, and Crenarchaeal cell division, and then review the current 
understanding of how ESCRT-III and Vps4 drive late stages of the pathway. 
 
ESCRT and MVB biogenesis 
        The ESCRT machinery was first identified in MVB biogenesis 16. MVBs are 
created during the sorting of various membrane proteins into intraluminal vesicles 
(ILVs) 16. Modification of cargo proteins by ubiquitin provides a signal for them to 




        Multiple ESCRT complexes function in different steps of MVBs biogenesis. 
The ESCRT proteins in yeast MVB biogenesis pathway will be outlined in this 
section, and they are conserved in higher eukaryotes, albeit with more variations.  
        ESCRT-0, which is comprised of a 1:1 complex HRS and STAM, functions 
in the recruitment of cargo proteins 14; 16; 17 (Figure 1.2 A). This heterodimer 
contains several ubiquitin binding motifs that can recognize ubiquitylated cargoes 
for recruitment 14. HRS also contains a FYVE domain that can bind PI(3)P and 
promote membrane association 18. Additionally, HRS contains a PSAP motif, 
which can bind to the ubiquitin E2 variant (UEV) domain of the ESCRT-I protein 







Figure 1.2. ESCRT-0 related protein complexes. 
A: Structure of the coiled-coil complex formed by the helical domains of HRS 
(Cyan) and STAM (Magenta) (PDB ID: 3F1I).  
B: Structure of the TSG101 UVE domain (Green) bound with PSAP motif from 
HRS (Cyan) (PDB ID: 3OBQ). 
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        ESCRT-I comprises four different proteins: Vps23(TSG101), Vps28, Vps37, 
and MVB12 14. Its core forms an elongated structure of ~18nm, which can be 
divided into a headpiece part and a stalk part 20 (Figure 1.3 A). The headpiece 
contains fragments from all four proteins and the stalk contains Vps23 (TSG101), 
Vps37, and MVB12 20 (Figure 1.3 A). The UEV domain of Vps23(TSG101), which 
can bind both the HRS PSAP motif 19 and ubiquitin 14, is linked to one end of the 
stalk. The C terminal domain of Vps28, which is linked to the headpiece, can bind 
the GLUE domain of the Vps36 ESCRT-II subunit, and thereby recruit ESCRT-II 







Figure 1.3. ESCRT-I related protein complexes. 
A: Structure of ESCRT-I heterotetramer core composed of Vps23 (TSG101) 
(green), Vps28 (red), Vps37 (magenta), and MVB12 (yellow) (PDB ID: 2P22).  
B: Structure of Vps28 C terminal domain (red) bound with Vps36 GLUE domain 
(orange) (PDB ID: 2J9U).  
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        ESCRT-II is a Y-shape heterotetramer comprising one copy of Vps36, one 
copy of Vps22, and two copies of Vps25 22 (Figure 1.4 A). The two copies of 
Vps25 form the two arms of the Y-shape structure, which can bind to two copies 
of Vps20, one of the ESCRT-III proteins 23 (Figure 1.4 B). In addition to binding 
ESCRT-I/Vps28  21, the Vps36 GLUE domain forms yet another ESCRT 
ubiquitin-binding domain 14. 
        In vitro studies using purified ESCRT proteins and giant unilamellar vesicles 
(GUVs) indicated that ESCRT-I and ESCRT-II complexes can deform the 
membrane to project a nascent bud, which remains attached to the membrane, 
into the GUV 24. ESCRT-I and ESCRT-II recruit ESCRT-III, which drives fission to 
sever the neck connecting the bud to the GUV 24; 25.  
        There are four core ESCRT-III proteins in yeast: Vps20, snf7, Vps24, and 
Vps2 16. Vps20 can be recruited by Vps25 of ESCRT-II 23 (Figure 1.4B). Vps20 
then recruits Snf7, the most abundant subunit in assembled ESCRT-III 
complexes, which can form large polymers on the membrane 26; 27. Snf7 in turn 
recruits Vps24 and Vps2 26. Vps24 functions as a capping protein to limit Snf7 
polymerization 26; 27. Vps2 can recruit the Vps4 ATPase complex, which 
disassembles ESCRT-III complexes and may function directly in membrane 
fission 26; 28. 
         Vps4, the only ATPase in the ESCRT machinery, provides energy for 
progression through the pathway. Vps4 contains an N-terminal MIT domain that 
binds with the C-terminal MIM motif of ESCRT-III proteins 28; 29; 30. This is 




Figure 1.4. ESCRT-II related protein complexes. 
A: Structure of ESCRT-II heterotetramer core composed of Vps36 (orange), 
Vps22 (blue), and two copies of Vps25 (pink) (PDB ID: 2ZME).  
B: Structure of hVps25 (EAP20) C terminal domain WH2 domain (pink) bound 




ATPase proteins typically function as oligomers 32; 33, and Vps4 appears to be 
functional as a hexamer in the presence of ATP (see Chapter 2). Vps4 uses the 
energy from ATP hydrolysis to disassemble ESCRT-III complexes and may also 
function directly in the membrane fission event 34. Disassembly of ESCRT-III 
complexes may lead to recycling of ESCRT-III protein, although the mechanism 
is not clear yet 24; 25. ESCRT-III and Vps4 drive fission and recycling; they are the 






ESCRT and HIV-1 budding 
        Many different classes of viruses use the ESCRT machinery to egress cells, 
with the most extensively studied being HIV-135; 36. HIV is a retrovirus whose 
virion displays a membrane that is derived from the plasma membrane of the 
host cells 35; 36. To be released from the host cells, an ESCRT-driven membrane 
fission step is necessary to ‘cut’ the linkage between the budding virion and the 
host membrane 35; 36. ESCRT machinery was recruited to the budding site by the 
HIV Gag protein, which is the major structural polyprotein of the virus and 
includes a C-terminal p6 domain that contains two different late (L) domains that 
recruit early-acting ESCRT protein/complexes 6; 37. There are two different late 
domain motifs in p6: PTAP and YPXL 6; 37. 
        The Gag/p6 PTAP (proline-threonine-alanine-proline) motif binds to a 
hydrophobic groove on the ubiquitin E2 variant (UVE) domain of the TSG101 
subunit of ESCRT-I 19 (Figure 1.5 A). This interaction mimics the interaction 
between the TSG101 UVE domain and the PSAP motif of the ESCRT-0 subunit 
HRS (Figure 1.2 B) 19, thereby explaining how HIV-1 can be recruited as an 
ESCRT pathway substrate 6. 
        The YPXL (tyrosine-proline-x-leu; x refers to any 1 or 3 residue(s)) motif 
binds the V domain of the cellular protein ALIX 38; 39. ALIX contains an N-terminal 
Bro1 domain, followed by a V domain and a C-terminal proline-rich C-terminal 
domain (PRD) 38. The YPXL motif binds to arm-2 of the V domain, with the bulky 
side-chain of the tyrosine inserted into a hydrophobic pocket on the V domain 







       
Figure 1.5. Recruitment of ESCRT machinery by HIV late domain. 
A: Structure of the complex formed by HIV PTAP motif (yellow) and TSG101 
UVE domain (green) (PDB ID: 3OBU).  
B: Structure of the complex formed by HIV YPXL motif (yellow) and Alix (blue) 




pocket 38; 39 (Figure 1.5 B). Recently, this interaction was found to mimic the 
interation between the YPXL motif of human syntenin and ALIX 40. Thus, both of 
the ESCRT interacting motifs on HIV Gag mimic the existing ESCRT interacting 
motifs in human cells to recruit ESCRT machinery. Following ALIX and/or 
ESCRT-1 complexes, the late ESCRT proteins including ESCRT-III and Vps4 are 
recruited to the virus budding sites. 
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        ESCRT-III and Vps4 are the executors of the membrane fission step during 
HIV budding 36. Despite extensive study, it is still not clear how TSG101 recruits 
ESCRT-III 36. ESCRT-II complex bridges ESCRT-I and ESCRT-III in MVB 
biogenesis, but it seems not to be necessary for the HIV budding process based 
on RNAi knock down studies 41. However, in vitro studies using GUV and purified 
proteins indicate that ESCRT-II co-localizes with ESCRT-I and the Gag protein 42. 
Thus, whether ESCRT-II or some other protein(s) bridging ESCRT-1 and 
ESCRT-III during HIV budding remains an open question. 
        How the alternative YPXL-ALIX pathway recruits ESCRT-III proteins is 
relatively clear 36. The N-terminal Bro1 domain of ALIX binds the CHMP4 
ESCRT-III subunits 43 (Figure 1.6). The C-terminal residues of CHMP4 proteins 
form an amphipathic helix, with its hydrophobic surface binding to the concave 
surface of the banana-shaped Bro1 domain 43 (Figure 1.6). Thus, ALIX can 
bridge the HIV Gag protein and the ESCRT-III complexes, with its V domain 
binding to the YPXL motif of Gag protein and its Bro1 domain binding to the C-




Figure 1.6. Recruitment of ESCRT-III by ALIX. 
Structure of the complex formed by ALIX Bro1 domain (blue) and the C-terminal 




        The ESCRT-III proteins recruited by ALIX induce membrane fission at the 
neck that connects the HIV virion and the plasma membrane of the host cell. 
There are 12 ESCRT-III proteins in human cells: the charged multivesicular 
protein (CHMP) variants 1A, 1B, 2A, 2B, 3, 4A, 4B, 4C, 5, 6, and 7, and IST1 16. 
Of these ESCRT-III proteins, only CHMP2 and CHMP4 proteins are necessary 
for the HIV budding process 44. CHMP2A and CHMP4B bind each other in an 
interaction that is necessary for HIV budding 44. While the C-terminal residues of 
CHMP4 bind ALIX, the C-terminal residues of CHMP2 proteins contain an MIM1 
motif that binds the MIT domain at the N-terminus of Vps4 29.  
        There are two Vps4 isoforms in human cells, VPS4A&B 16. Knocking down 
both VPS4A and VPSB can inhibit HIV budding, and this inhibition can be 
rescued by expressing VPS4B alone 30. Thus, it seems VPSB alone is sufficient 
for accomplishing HIV budding. 
 
ESCRT and cytokinesis 
        The last step of cytokinesis is abscission, by which one cell is split 
topologically into two daughter cells 45; 46. This step is mediated by ESCRT 
machinery 46. Immediately prior to abscission, the two daughter cells are 
connected by a structure known as the midbody 45. Different ESCRT 
proteins/complexes are recruited to the midbody 46. Similar to the HIV budding 
process, TSG101 and ALIX are the early-acting ESCRT machinery recruited to 
the membrane fission site 10; 46; 47. 
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        The midbody protein CEP55 is responsible for recruiting the ESCRT 
machinery 10; 47. CEP55 contains an ESCRT- and ALIX-binding region (EABR) 
(160-217) to recruit the ESCRT-1 subunit TSG101 and ALIX 47. Two copies of 
EABR form a coiled-coil dimer that contains one binding site for TSG101 or ALIX 
47 (Figure 1.7). The proline-rich tail of ALIX contains a GPPX3Y motif that binds to 
the EABR of CEP55 47 (Figure 1.7). The GPPX3Y motif wraps around the 
protruding side chain of Tyrosine187 of the EABR motif of CEP55 47 (Figure 1.7). 
The two proline residues on the GPPX3Y motif form a hydrophobic interface with 
the side chains of Tryptophan184 and Tyrosine187 of the EABR motif 47 (Figure 
1.7).  The side chain of the C-terminal GPPX3Y Tyrosine also contributes to the 
binding to EABR by (1) inserting between the two bulky side chains of 
Tyrosine187 and Tryptophan194 of the EABR and (2) forming a hydrogen bond 
to the side chain of Glutamate192 of EABR 47 (Figure 1.7). The ESCRT-I subunit 
TSG101 also contains a GPPX3Y motif, which can compete with ALIX for binding 
to EABR 47. This indicates that one copy of EABR dimer can only bind to one 




Figure 1.7. Recruitment of ESCRT machinery by CEP55. 
Structure of the complex formed by CEP55 EABR dimer (purple) and GPPX3Y 
motif of ALIX (blue) (PDB ID: 3E1R). 
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        Similar to the HIV budding process, how ESCRT-III is recruited by ESCRT-I 
for cytokinesis is not clear, and ESCRT-II appears not to be required 10. Also 
similar to HIV budding, ALIX appears to recruit the ESCRT-III subunit CHMP4 43.  
        Besides Vps4, another AAA ATPase called spastin is also recruited to the 
midbody 48. Like Vps4, spastin contains an MIT domain, which is known to 
interact with the C-terminal MIM tail of CHMP1B 48. This interaction is important 
for the recruitment of spastin to the midbody, which permits the spastin to cleave 
the microtube at the abscission site, accomplishing a vital aspect of cytokinesis 48. 
 
ESCRT and exosome budding 
        Exosomes are a class of secreted extracellular vesicles containing 
molecules involved in cell-cell communication 40. Cargo molecules are attached 
to the membrane of endosomes and the membrane buds into the intro lumen to 
from MVBs with the help of the ESCRT machinery 40. Recruitment of the ESCRT 
machinery during this step is accomplished by the syndecans-syntenin-ALIX 
bridge 40. Finally, exosomes are released to the outside of cells by fusion of 
MVBs with plasma membrane 40.  
        Syndecans are ubiquitous transmembrane proteins that are important for 
exosome biogenes, which contain a short cytoplasmic domain which can bind to 
Syntenin 40. Syntenin contains a 100-amino acid N-terminal domain, two PDZ 
domains, and a C-terminal domain 40. The N-terminal domain contains three 
LYPXnL motifs which can bind to the V domain of ALIX. ALIX will then recruit the 
ESCRT-III proteins 40. The LYPXnL motif has been identified in the late domain of 
13 
 
the HIV Gag protein, which also recruits ALIX during the HIV budding process 37; 
38; 39. So, HIV uses a sequence motif from syntenin to hijack the ESCRT 
machinery to complete the membrane fission step of the virion budding process. 
 
ESCRT in Crenarchaea 
        Homologs of components of the ESCRT machinery have also been 
identified in some Crenarchaeal species 49; 50. It has been shown to be involved 
in the cell division process and to be hijacked by the virus of archaeal species 12; 
13; 51. This indicates that the ESCRT machinery is conserved during evolution. 
Three genes cdvA, cdvB, and cdvC, which are under the same operon, constitute 
the ESCRT machinery in Crenarchaea 52. 
        CdvA was predicted to contain an N-terminal beta-barrel domain followed by 
an alpha-helix-rich region and a C-terminal tail 53. CdvA can interact with the lipid 
membrane, and the membrane binding motif(s) exist in the C-terminal region 
including the helix-rich region and the C-terminal tail 53. The C-terminal tail of 
CdvA can interact with the C-terminal winged-helix (wH)-like domain of CdvB 
(Figure 1.8 A), which is necessary to recruit CdvB to the membrane 53. The C-
terminal tail was named E3B (ESCRT-III binding) 53. 
        EM study of purified CdvA from Metallospherae sedula indicated that it can 
form double helical filaments with diameter ranges from 8 to 11 nm in vitro 53. 
This structure can be stabilized by DNA, which is similar to the known bacterial 
DNA partitioning proteins 53.  The biological significance of these double helical 




Figure 1.8. ESCRT complexes from Crenarchaea. 
A: Structure of a complex formed by C-terminal tail of CdvA (purple) and C-
terminal wH-like domain of CdvB (green) (PDB ID: 2XVC). B: Structure of a 
complex formed by CdvB MIM motif (green) and CdvC MIT domain (cyan) (PDB 
ID: 2W2U). 
 
         
        CdvB is the paralog of ESCRT-III protein 52. It contains an ESCRT-III core 
fold on the N-terminus, a MIM2 motif which can interact with the MIT domain of 
CdvC (Vps4)12, and a C-terminal wH-like domain which can interact with the C-
terminal tail of CdvA 53. Three other ESCRT-III like proteins have also been 
discovered in S. solfataricus, but their implication in cell division is not clear yet 12.  
        Purified N-terminal ESCRT-III core fold of CdvB can form filaments in vitro, 
which is similar to the eukaryotic ESCRT-III proteins 52. The MIM2 motif following 
the ESCRT-III core fold can bind to the groove between helix 1 and helix 3 of the 
MIT domain of CdvC 12 (Figure 1.8 B), which is very similar to the interaction 
between the MIM2 of hCHMP6 and MIT of Vps4A.  
        The C-terminal winged-helix region of CdvB contains a “broken” wing 
(Figure 1.8A). The classic wH fold usually contains three beta strands. The C-
terminal wH fold of CdvB contains only two beta strands, and E3B region from 
CdvA binds between the two beta strands of CdvB to form the third beta strands 
53 (Figure 1.8 A). So, the C-terminal region of CdvB and the C-terminal E3B tail of 
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CdvA form a classic wH-fold together 53. This interaction is necessary for 
recruiting CdvB to the membrane as the CdvB cannot bind to the membrane by 
itself 53. 
        CdvC is the paralog of Vps4 in Crenarchaeal species 52. It is structurally 
similar to eukaryotic Vps4 (see Chapter 2). It consists of an N-terminal MIT 
domain, a linker region, and a C-terminal AAA+ ATPase cassette. The MIT 
domain is a three-helix-bundle, which can interact with the MIM2 motif of CdvB 
(Figure 1.8 B). We determined the structure of the C-terminal AAA+ ATPase 
cassette recently, which is very similar to the structure of Eukaryotic Vps4 (see 
Chapter 2). Like eukaryotic Vps4, CdvC also forms a ring-like oligomer, which is 
thought to be the active form 52. Consistent with their living environment, CdvC 
from thermophilic Crenarchaeal species can hydrolyze ATP only under high 
temperature 52. 
 
ESCRT-III mediated membrane fission 
        ESCRT-III proteins are required for all of the identified ESCRT-involved 
biological events, as they execute the membrane fission step 14. There are seven 
different ESCRT-III proteins in yeast and 12 different subunits in human cells 16. 
The sequence similarity among these proteins is low, but their 3D structures are 
quite similar based on the solved structure of some ESCRT-III proteins and 
secondary structure predictions 14; 54; 55; 56. The N-terminal four helices form the 
core structure of ESCRT-III, and the 5th helix fold back onto the helix 1 and helix 
16 
 
2 of the core 54; 55; 56(Figure 1.9). Some ESCRT-III proteins contain an MIM (MIT 
interacting Motif) on their C-terminus 28; 29; 30; 57. 
        ESCRT-III proteins have two different states: monomer in the solution and 
large polymers when they bind to the membrane 14; 16. In the monomeric state, 
the fifth helix of ESCRT-III proteins folds back onto the N-terminal helix core to 
inhibit the assembly of ESCRT-III proteins 54 (Figure 1.9). Removal of the fifth 
helix or site-directed mutagenesis to disrupt the interaction between fifth helix 
and the N-terminal helix core will favor the assembly of ESCRT-III proteins in 
vitro 54. However, recent EM reconstructions of lipid-associated Ist1/CHMP1 
copolymers indicate helix 5 may play important roles in bridging different subunits 
within the ESCRT-III polymer (unpublished data from Dr. Frost), which seems 
consistent to our model that helix 5 is the Vps4-ATPase cassette binding motif 




Figure 1.9. Structure of ESCRT-III protein. 
Two different conformations of ESCRT-III proteins, represented by structures of 
CHMP3 (adapted from PDB files 3FRT and 3FRV). Left: autoinhibited 
conformation which favors the soluble, monomeric state. Right: open 
conformation induced by membrane binding, which favors the polymerization.  
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        Assembled ESCRT-III proteins have been observed in both cultured cells 
and in vitro assays 14. Overexpressed CHMP4 protein, one of the ESCRT-III 
subunits, can assemble into ~5 nm filaments which form circular arrays on the 
cytoplasmic face of the plasma membrane 58. When co-overexpressed with the 
hydrolysis-defective mutant of Vps4B, the CHMP4 filaments can deform the 
membrane to protrude toward the outside of the cell 58. Similar protrusions can 
also be observed when only overexpressing the N-terminal core domain of 
CHMP4A (1-116) 58. Helical filaments of 17 nm diameters were also observed 
around the membrane abscission site during cytokinesis, which was speculated 
to be or contain ESCRT-III proteins because the filaments cannot be observed in 
CHMP2A-depleted cells 59. Purified ESCRT-III proteins can assemble into 
filaments or tubes in vitro, which can be disassembled by Vps4 in the presence 
of ATP 34. The ESCRT-III tubes formed in the presence of lipid membrane 
contain cone-shape ends, which were proposed to induce membrane fission 34. 
        In vitro studies with GUV and purified ESCRT proteins indicate that ESCRT-
III proteins can finish the membrane fission process as long as there is enough 
ESCRT-III supply 25. Three of the four core ESCRT-III proteins are sufficient for 
one round of membrane fission: Vps20, snf7, and Vps24 25. Vps20 can be 
recruited to the membrane fission site by ESCRT-II complexes, then recruits snf7 
25. Adding Vps24 can make the membrane fission step much more efficient 25. 
Vps2 is in charge of recruiting Vps4, which is implied to recycle ESCRT-III 
proteins for further usage with the energy from ATP hydrolysis 25. In vivo studies, 
however, indicate that Vps4 may actively participate in the fission step 60; 61; 62. 
18 
 
        Several different models have been proposed for the mechanism of 
membrane fission induced by ESCRT-III and Vps4 14. The spiraling dome model 
is one leading model among them 14. According to the dome model, ESCRT-III 
proteins can form spirals when they bind to the membrane 14. These spirals will 
form a dome-like structure at the membrane fission site 14. Opposing membranes 
bound to the top end of the dome will be pulled together, which will constrict the 
membrane neck and finally lead to membrane fission 14.  
 
Vps4 
        Vps4 is an AAA+ ATPase that disassembles ESCRT-III complexes with the 
energy from ATP hydrolysis 34. It is the only ATPase in the ESCRT machinery to 
provide energy for membrane fission. 
        Vps4 contains an MIT domain on the N-terminus, an AAA+ ATPase 
cassette on the C-terminus, and a linker region between them 14; 16 (Figure 1.10). 
The N-terminal MIT domain is a three-helix bundle, which can selectively 
recognize the MIM motifs on the C-terminal of ESCRT-III proteins 28; 29; 57 (Figure 
1.10). Two different MIM motifs have been identified to bind to the Vps4 MIT 
domain: MIM1 which binds to the groove between the 2nd and 3rd helix of MIT 
domain and MIM2 which binds to the groove between the 1st and 3rd helix of 
MIT 28; 29; 30 (Figure 1.10). The C-terminal AAA+ ATPase cassette contains the 
large ATPase domain and the small ATPase domain, which form the ATP 
binding/hydrolysis pocket together 31; 63; 64; 65. For Eukaryotic Vps4, there is a beta 




Figure 1.10. Structure of Vps4. 
Right: Structures of the MIT domain (PDB ID: 2JQH) and the monomeric AAA+ 
ATPase Cassette (PDB ID: 1XWI) of human VPS4B.  
Bottom left: Structures of the complex formed by MIT domain (VPS4A) and MIM1 
motif (CHMP1A) (2JQ9) and the complex formed by MIT domain (VPS4B)-MIM2 
motif (CHMP6) (2K3W).  
Top left: Structure of the complex formed by Vta1p VSL domain and a fragment 





for the VSL domain of the Vps4 activator Vta1 (LIP5 in human cells) which can 
stabilize Vps4 oligomer 31 66(Figure 1.10). Several structures of the Vps4 AAA+ 
ATPase cassette from different species have been determined by crystallography 
and these structures can be superimposed to each very well, which indicates the 
3D structure of AAA+ ATPase cassette of Vps4 is very well conserved through 
evolution 31; 63; 64; 65; 67. 
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        Similar to other AAA+ ATPases, the active form of Vps4 is an oligomer 68. 
Several EM or Cryo-EM studies indicate that the Vps4 oligomer is a double-ring 
structure in the presence of ATP, which contains 12 or 14 subunits 69; 70; 71. Two 
of these three EM or Cryo-EM reconstructions of Vps4 oligomer were using a 
Vps4p mutant containing the E to Q mutation on the Walker B motif, which can 
still bind ATP but cannot hydrolyze ATP 69; 71. Recently, our group found that the 
wild type Vps4p is in an equilibrium between hexamer and dimer in the presence 
of ATP (see Chapter 2), which indicates that the functional form of Vps4 is a 
hexamer. 
        A hexamer model of Vps4 has been proposed based on the D1 ring of p97, 
a closely-related AAA ATPase 31 (Figure 1.11). This model was proven to be 
largely valid based on two observations. First, the predicted hexameric interface 
residues based on the hexamer model were shown to be important for 
oligomerization and function of Vps4 31; 64. Second, the predicted central pore 
loops are important for the function of Vps4. There are two pore loops lining the 
central pore of this hexamer model 31; 64 (Figure 1.11). The pore loops of AAA+ 
ATPases have been shown to be the substrate binding/processing motifs 32; 33; 72; 
73; 74. Human cell VPS4A/B carrying mutations on these pore loops, although they 
can still assemble into oligomers, cannot support efficient HIV budding, which 
indicates these pore loops are important for the function of Vps4 31; 64. Based on 
this model, the ATP binding sites are between the two neighbor subunits within 





Figure 1.11 : Hexamer model of Vps4. 
The p97-like hexamer model of Vps4 built with the structure model of Vps4p 
ATPase cassette (PDB ID: 3EIH) superimposed on the D1-ring of p97 (PDB ID: 
1E32). Important residues of pore loop 1 (orange) and pore loop 2 (green) are 




        The activity of Vps4 is regulated by several ESCRT proteins, including 
Vta1/LIP5 and ESCRT-III proteins 75; 76; 77. Vta1/LIP5 contains a tandem MIT 
domain on the N-terminus and a VSL (Vta1 SBP1 LIP5) domain on the C-
terminus 77. The MIT domains can bind to the MIM motifs of Did2 and Vps60 75; 78; 
79. The C-terminal VSL domains can dimerize, which is necessary for the function 
of Vta1 77. The VSL domain is also responsible for binding to the beta domain of 
Vps4, which can stabilize the Vps4 oligomer 66; 77. Adding the VSL domain can 
increase the ATPase activity of Vps4 75. Although one structure of the interface 
between the Vta1-VSL domain and the Vps4-beta domain has been reported 
66(Figure 1.10), it is still not clear about how the VSL domain stabilizes the Vps4 
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oligomer. One model proposed that the VSL domain can crosslink different Vps4 
oligomers 66 and the other model stated that the VSL domain crosslinks different 
subunits within one Vps4 oligomer 67. There is also a long linker between the MIT 
domains and the C-terminal VSL domain, which has been indicated to have a 
regulatory role on the activity of Vps4 80. 
        In addition to Vta1, ESCRT-III proteins also play important roles in 
regulating the activity of Vps4 with different mechanisms.  
        First, ESCRT-III proteins can regulate the ATPase activity of Vps4 directly. 
The C-terminal residues of the ESCRT-III proteins CHMP2A, CHMP1B, CHMP3, 
CHMP4A, CHMP6, and CHMP5 have been shown to stimulate the ATPase 
activity of VPS4A in a manner that is independent of Vta1/LIP5 76. Similar 
stimulation effect has also been reported for Vps2 75. Both the C-terminal MIM 
motif and the upstream 5th helix of ESCRT-III proteins are necessary to this 
regulation, but neither of them seems to be able to activate the ATPase activity of 
full-length Vps4p alone 75; 76. The 5th helix of ESCRT-III proteins has been 
reported to form the secondary Vps4 binding site because it can mediate the co-
precipitation of overexpressed CHMP2A and Vps4B(E235Q) 81. We found that 
the 5th helix can mediate the direct interaction between ESCRT-III and the 
central pore of Vps4 ATPase cassette, and this interaction can stabilize the Vps4 
hexamer, which supports that one mechanism for the stimulation of the ATPase 
activity of Vps4 is that interacting with ESCRT-III proteins stabilizes the 
oligomerization of Vps4 (see Chapter 4). 
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        Second, ESCRT-III proteins can also regulate the ATPase activity through 
Vta1/LIP5. Both Did2 and Vps60 contain MIM motifs binding to the MIT domains 
of Vta1 75. Particularly, the Vps60 contains a very unique MIM5 motif, which is 
composed of helix 4 and helix 5 of Vps60 78; 79. These two helices wrap around 
the helix bundle of the Vta1_MIT2 domain 78; 79. Did2 contains a C-terminal tail 
that binds to the MIT domains of Vta1 77. Both Did2 and Vps60 stimulate the 
ATPase activity of Vps4p in a Vta1-dependent way 75. The mechanism of this 
regulation is not yet clear.  
        In vitro experiments with GUV and purified ESCRT proteins indicate that 
ESCRT-III proteins are sufficient for membrane fission, and Vps4 functions to 
recycle ESCRT-III proteins through disassembling ESCRT-III complexes to 
monomeric ESCRT-III proteins 25. However, in vivo studies show that Vps4 is 
recruited to the membrane fission site before membrane fission started 60; 61; 62, 
which implied that Vps4 may actively participate in the membrane fission process. 
So, the exact the role of Vps4 in membrane fission is not yet clear. Moreover, 
how Vps4 disassembles the ESCRT-III complexes is also not yet clear. The 
published data, as well as our own data, supported the model that Vps4 hexamer 
disassembles ESCRT-III complexes by pulling the C-terminal region of ESCRT-
III subunits into/through the central pore of the Vps4 hexamer 14; 31; 64; 76 (see 
Chapter 4). More research is still needed to validate this model, especially the 
high resolution structural information of how ESCRT-III complexes are built and 





       Vps4 belongs to the AAA+ ATPases (ATPases Associated with diverse 
cellular Activities) superfamily 1. AAA stands for ATPases associated with a 
variety of cellular activities 82.  AAA+ ATPases hydrolyze the gamma phosphate 
bond of ATP, and utilize the energy from ATP hydrolysis to change the 
conformation of other biomolecules (substrates) 32; 82. They act like motors on the 
molecular level.  The AAA ATPases family was first defined for proteins that 
contain the conserved AAA ATPase module, such as the regulatory subunits 
(Rpt1-6) of 26S proteasome and NSF which is involved in vesicle fusion 82. 
Sequence alignments identified proteins more distantly related to the AAA 
ATPase family 82. All of them, including the AAA ATPases, share some distinct 
structural features, and they are designated the AAA+ ATPases superfamily 32; 33; 
82. 
        The AAA+ ATPase cassette is composed of an N-terminal large ATPase 
domain and a C-terminal small ATPase domain 32; 33; 82 (Figure 1.12). The large 
ATPase domain is an alpha-beta-alpha fold, which contains a beta-sheet of 5 
parallel strands (beta 1-5) surrounded by five alpha helices (alpha 0-4) 16; 33; 82. 
The C-terminal small ATPase domain is a helical bundle of four alpha helices 
(alpha 5-8) 32; 33; 82. The ATP binding/hydrolysis pocket is formed between two 
neighbor subunits of an AAA+ ATPase oligomer, and both of the large and small 
ATPase domain are required  32; 33. There are six important structural features of 
the AAA+ ATPase cassette: Walker A, Walker B, Sensor 1, Sensor 2, Arginine 





Figure 1.12. Structure features of AAA+ ATPases. 
The structure of NSF hexamer is shown (PDB ID: 1NSF). Two NSF monomers 
next to each other within one hexamer are colored green and blue. The important 




        The Walker A motif is located between beta1 and alpha1 32; 33. The crucial 
residue is a lysine residue in the consensus Walker A sequence GxxxxGKT/S (x 
is any amino acid)32; 33. AAA+ ATPases with mutation on the conserved K cannot 
bind ATP 32.  
        The Walker B motif starts from beta3 to the alpha3 with the consensus 
sequence hhhhDE (h is hydrophobic residue) 32; 33. The conserved aspartate 
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residue coordinates Mg2+ which is necessary for ATP hydrolysis 32. The following 
glutamate activates a water molecule for ATP hydrolysis 32. Mutating this 
glutamate residue to glutamine does not impair ATP binding ability but 
inactivates the ATPase activity 32. 
        The sensor II motif is at the beginning of the alpha 7 of the small ATPase 
domain 32. It contains a consensus arginine interacting directly with the gamma 
phosphate of ATP 32.  
         The sensor I and the arginine figure(s) constitute the second region of 
homology (SRH) 32. Sensor I is a polar residue at the end of beta 4, which is 
usually an asparagine 32. This polar residue works together with the glutamate of 
Walker B motif to activate a water molecule to attack the gamma-phosphate of 
ATP during ATP hydrolysis 32. The arginine finger is at the end of the alpha 4 32. 
The active form of AAA+ ATPases is oligomer, in which the arginine finger from 
one subunit and other important elements from the neighbor subunit, including 
Walker A, Walker B, Sensor I, and Sensor II, cooperate to form one ATP binding 
and ATP hydrolysis pocket 32 (Figure 1.12). 
        Another important feature of AAA+ ATPases is the pore loop which points 
toward the central hole of the AAA+ ATPase oligomer 32. A conserved motif Ar-
Φ-G (Ar: Aromatic residue, Φ: Hydrophobic residue, and G: Glycine) on the loop 
between beta 2 and alpha 2 constitutes the pore loop 32. The pore loop is the 
substrate (not ATP) binding motif 32.  
        The active forms of AAA+ ATPases are generally highly ordered oligomers 
32; 33. Most reported AAA+ ATPases form ring‐like oligomers as the active form 33. 
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Binding of ATP, substrate, or other factors may be necessary or helpful for the 
oligomerization 32; 33. Ring‐like ATPase oligomers can use the energy from ATP 
hydrolysis to perform diverse cellular functions such as DNA or DNA/RNA duplex 
unwinding and protein unfolding 32; 33; 83. The mechanisms of ring‐like ATPases 
have been studied extensively, and three models have been proposed: a 
concerted model, a stochastic model, and a rotary model 83. The concerted 
model states that all of the subunits around the ring have the same ATP 
hydrolysis states 83. The stochastic model states that the ATP hydrolysis states of 
different subunits around the ring are randomly distributed 83. The rotary model is 
the most favored model, as several structures of AAA+ ATPases or RecA‐like 
ATPases support this model, including F1‐ATPase, E.coli Rho helicase, and 
papillomavirus E1 helicase 74; 84; 85. According to this model, the different subunits 
around the ring hydrolyze ATP in a certain sequence, clockwise or 
counterclockwise 83. Loops or other motifs projecting towards the central pore of 
the ring are responsible for binding and reforming or moving of the substrates 83. 
The conformation and/or position of these loops of different subunits have 
different states according to the ATP hydrolysis states of these subunits 83. 
 
Outline of chapters 
        This introduction is followed by four chapters. Chapters 2-4 document my 
efforts towards understanding how Vps4 works, while Chapter 5 summarizes my 
current understanding and envisions the future direction of research on Vps4.  
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        Chapter 2 reports the discovery of Vps4 hexamer as the active form of Vps4 
and two structures of AAA+ ATPase cassette of Crenarchaeal Vps4 homologs in 
collaboration with Dr. Monroe. In contrast to the prevailing double ring models 69; 
70; 71, our size exclusion chromatography and analytical ultracentrifugation 
analyses of wild type Vps4p supported the model that Vps4 is active as a single 
ring hexamer. We further support the proposal that the Vps4 hexamer resembles 
the p97 D1-ring structure through mutagenesis of residues as the proposed 
interface 31; 64.  This chapter also describes the solution association states and 
crystal structures of the AAA+ ATPase cassettes of two crenarchaeal Vps4 
homologs. Both structures are very similar to the AAA+ ATPase cassette of 
eukaryotic homologs, and although neither crystalize as hexamers, both crystal 
lattices preserve a packing interface that resembles the hexameric interface of 
the p97-like Vps4 hexamer model. Finally, we showed that mutation on this 
interface disrupts oligomerization of Crenarchaeal Vps4 homologs and impairs 
their ATPase activity, indicating that this interface is conserved through evolution.  
This chapter was published recently in the Journal of Molecular Biology 67. Dr. 
Monroe performed the analysis of the oligomerization of Vps4, and I contributed 
the two crystal structures of of the AAA+ ATPase cassettes of two Crenarchaeal 
Vps4 homologs and biochemical characterization of them. 
        Chapter 3 documents crystallization efforts toward a structure of the Vps4 
hexamer. Different strategies were used, including screening Vps4 homologs 
from different Crenarchaeal species, stabilizing association by fusion with 
another protein that forms a stable hexamer, stabilizing the Vps4p hexamer by 
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addition of the Vta1p VSL domain, and stabilizing a functional asymmetric 
hexamer by use of ADP·AlFx and addition of a substrate peptide. Although a lot 
of crystal hits were obtained, no crystals that diffracted to sufficient resolution to 
determine the crystal symmetry were found that could contain a Vps4 hexamer. 
        Chapter 4 describes characterization of the interaction between the Vps4p 
hexamer and residues from helix 5 of Vps2, one of the ESCRT-III proteins in 
Saccharomyces cerevisiae. The equivalent region in a homologous ESCRT-III 
protein had been shown to activate the ATPase activity of Vps4A 76, and the 
sequence around the helix 5 of the human CHMP2A ESCRT-III subunit was 
known to be important for co-precipitation of overexpressed CHMP2A and 
Vps4B(E235Q) 81. Consistent with these earlier observations, I found that that 
helix 5 of Vps2 can interact directly with the pore loops of the Vps4p hexamer, 
and one ∆MIT-Vps4p hexamer can bind one substrate. Furthermore, I 
demonstrated that the interaction required ADP·AlFx, an ATP analog mimicking 
ATP, ADP, and the transition state of ATP during ATP hydrolysis. These data 
indicate that the functional Vps4 hexamer is asymmetric.  
        We also found that the interaction with the pore loops of the Vps4p hexamer 
may be limited to residues of helix 5 of the ESCRT-III subunits. In particular, my 
data indicate that a patch of negatively charged residues adjacent to the N-
terminus of helix 5 of Vps2 may serve as a stop translocation signal when they 
reach a collar of negatively charged residues around the central pore of the 
Vps4p hexamer. The resulting charge-charge repulsion may function to prevent 
the N-terminal four helices of ESCRT-III protein from being processed by Vps4. 
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        Finally, Peptide binding to the Vps4p pore loops was found to be 
autoinhibited by the MIT domain on the N-terminus of Vps4p. Moreover, binding 
of the C-terminal Vps2p MIM1 motif to the Vps4p MIT domain alleviated this 
autoinhibition. These data suggest an autoinhibiory regulatory mechanism that 
functions to prevent processing of nonspecific proteins by Vps4.  
        This chapter is a manuscript in preparation that reports a detailed 
characterization of the interaction between peptides derived from ESCRT-III 
substrates with the AAA ATPase domain of Vps4. I did all of the biochemical 
analysis of Vps4p-Vps2p interaction; Dr. Joerg Votteler from Prof. Sundquist’s 
Lab confirmed the importance of the pore loop 2 of Vps4 in HIV budding system. 
        Chapter 5 summarizes all of the biochemical and structural studies on Vps4 
in Chapter 2-4 and proposes some possible experiments in three directions for 
future studies of Vps4, including crystallization of the Vps4 hexamer and ESCRT-
III disassembly by Vps4. 
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CRYSTALLOGRAPHIC EFFORTS TOWARDS  




         Vps4 contains an N-terminal MIT domain and a C-terminal AAA+ ATPase 
cassette 1; 2. The MIT domain can selectively bind MIM motifs on ESCRT-III 
proteins 3; 4; 5. The structures of MIT domains and monomeric AAA+ ATPase 
cassettes have been reported by several groups 1; 6; 7; 8; 9. Like other proteins 
within the AAA+ ATPase family, Vps4 functions as an oligomer 10. The details of 
Vps4 oligomerization have been controversial, and several very different 
molecular models from EM or Cryo-EM reconstructions have been proposed 7; 11; 
12. Vps4p with a mutation on the Walker B motif (E233Q) has been reported to 
form a dodecamer 1; 10, which is consistent with the model from EM or Cryo-EM 
reconstruction of Vps4p(E233Q) 11; 12. Recently, we found that wild type Vps4 
can form a hexamer in the presence of ATP, and concluded that Vps4 is active 
as a hexamer (Chapter 2). I have pursued four different strategies in an attempt 
to obtain crystals of the Vps4 oligomer suitable for structure determination: (1) 
crystallization of Vps4 homologs from different Crenarchaeal species, (2)
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crystallization of the Vps4p:VSL complex, (3) crystallization of the templated-
Vps4p hexamer, and (4) crystallization of the Vps4p:substrate complex. 
 
 
Crystallization of Vps4 homologs from different Crenarchaeal species 
        ESCRT-III and Vps4 have been highly conserved throughout evolution, and 
function in the final stages of cell division in eukaryotes and the Crenarchaea 13; 
14. Crenarchaeal Vps4 displays the MIT domain and ATPase cassette of the 
eukaryotic proteins, but lack the beta-domain 15. Consistent with this, there is no 
gene encoding a homolog of Vta1p apparent in Crenarchaea 15; 16. Unlike the 
Vps4p of Saccharomyces cerevisiae, some Crenarchaeal Vps4 enzymes do not 
require ATP for oligomerization 17. Moreover, negative stain EM imaging of the 
Vps4 homolog from the hyperthermophilic archaeon Metallospherae sedula 
indicated a ring-like structure 17. Therefore, Crenarchaeal Vps4 homologs 
seemed like good candidates for crystallization of a Vps4 oligomer. 
 
 
Co-crystallization of a Vps4p:VSL complex 
        The VSL domain of Vta1p has been reported to stabilize Vps4p 
oligomerization and stimulate Vps4p ATPase activity 18; 19. The structure of the 
complex of the Vta1p VSL domain with the beta and the C-terminal domain of 
Vps4 has been reported 20. Surprisingly, however, this structure does not support 
the model that the Vps4 beta domain interaction with the Vta1p VSL stabilizes 
single Vps4 oligomer 20. Instead, it suggests that the dimeric VSL domain can 
cross-link different Vps4 oligomers into a network 20. Recently, we found that the 
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VSL domain does not change the oligomerization of wild type Vps4p in the 
presence of ATP (Chapter 2), which supports the first model that VSL domain 
stabilizes single Vps4 oligomer. We also found that the ATPase cassette of 
Vps4p can form a stable hexamer in the presence of the Vta1p VSL and 
ADP·AlFx, an ATP analog that can mimick a range of nucleotide states 
experienced during the ATP hydrolytic cycle (Chapter 4). I therefore tried to co-
crystallize the Vps4 ATPase cassette of Vps4p with the VSL domain of Vta1p in 
the presence of ADP·AlFx. 
 
 
Crystallization of the templated-Vps4p hexamer   
        Because we are confident that Vps4 is active as a hexamer that roughly 
approximates p97 D1 (Chapter 2), I designed a fusion with the stable hexameric 
protein CCMK4 21that is expected to preserve the stable Vps4 association.  The 




Crystallization of Vps4p:substrate complex 
        The most informative AAA+ ATPase structure is that of the Papillomavirus 
E1 helicase, whose success depended upon co-crystallization with nucleic acid 
substrate in the central pore 23. Although not an AAA+ ATPase, the highly 
informative rho helicase structure similarly depended upon co-crystallization with 
a central substrate 24.  Moreover, we have shown that active Vps4p is an 
asymmetric hexamer that is stabilized by binding of substrate protein in the 
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central pore (Chapter 4).  I therefore tried to use the same strategy to crystallize 
Vps4 hexamer in complex with a substrate Vps2/ESCRT-III helix 5 peptide that 
binds the Vps4 pore (Chapter 4).  
 
Materials and methods 
Plasmids 
        Plasmids encoding different Vps4 homologs from Crenarchaeal species, 
except Sulfolobus solfataricus, were synthesized by DNA2.0 (Menlo Park, CA, 
USA) with a cleavable N-terminal 6xHis-tag and cloned into pJexpress414 
(DNA2.0). A prescission protease cleavage site was placed between the His-tag 
and the Vps4 coding region. The gene encoding Sulfolobus solfataricus Vps4 
was amplified from the genome (ATCC 35092D-5) and inserted into the vector 
pET151D-topo. The TEV cleavage site between the His-tag and the Sulfolobus 
solfataricus Vps4 was replaced by a prescission protease cleavage site. Genes 
encoding Saccharomyces cerevisiae Vps4p and the VSL domain of Vta1p were 
also inserted into the vector pET151D-topo. These different mutations or 
truncations of Vps4p were created by Quikchange mutagenesis (Stratagene). 
 
 
Protein expression and purification 
        All of the proteins were expressed in BL21 Condon+ E.coli cells in ZY 
autoinduction media at 37°C until OD600 of 0.5 and then overnight at 21°C. The 
harvested cells were lysed in lysis buffer (20mM imidazole, 300mM NaCl, 25mM 
Tris) containing 10mg/ml lysozyme and protease inhibitors (PMSF (0.2mg/ml), 
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aprotinin (1.0µg/ml), leupeptin (1.0µg/ml), pepstatin (1.0µg/ml)) at 4°C for 1 hour 
followed by sonication. The pH of lysis buffer is different for different proteins. For 
Crenarchaeal Vps4 homologs, pHs from 6 to 9 were tried, and the optimal pH for 
each homolog is listed in Table 3.1. All of the twelve Vps4 homologs tested were 
soluble except the protein from Staphylothermus hellenicus. For Vps4p, its 
variants and the VSL domain of Vta1p, lysis buffer of pH7.4 was used. 
        After sonication, cell lysate of Crenarchaeal Vps4 homologs were incubated 
at 75°C for 15min. Cell lysates were centrifuged at 35,000g for 45min. The 
supernatants were collected and incubated with Ni-NTA agarose for 1 hour. The 
Ni-NTA agarose bound with protein was washed by at least 10x volume of lysis 
buffer, then eluted by elution buffer (400mM imidazole, 300mM NaCl, 25mM Tris, 
pH 7.5). The eluted proteins were incubated with TEV protease (~1mg/100mg, 
for Vps4p, its variants, and Vta1p VSL) or precision protease (~1mg/100mg, for 
Crenarchaeal Vps4) in cleavage buffer (150mM NaCl, 1mM EDTA, 1mM DTT, 
25mM Tris, pH 7.5) for 20 hours at 4°C to cleave the histidine tag.  After 
cleavage, the samples were run through the Ni-NTA agarose column to remove 
the uncleaved proteins. The flow-through containing the purified proteins was 
collected. For Vps4p and its variants, a further step of purification on a Q column 
was applied. Specifically, Vps4p in buffer A (100mM NaCl, 20mM HEPES, pH 
7.5) was loaded onto the HiTrap Q HP (GE Healthcare Life Sciences). The 
column was washed with 5x volume of buffer A, and the protein eluted by a 
gradient (0-35%) of buffer B (1M NaCl, 20mM HEPES, pH 7.5). For 
Crenarchaeal Vps4 homologs, a further step of purification by size exclusion  
60 
 
Table 3.1. Different Crenarchaeal Vps4 homologs tested for expression. 
 




chromatography with SD200 column was applied. The purified proteins were 
dialysed into low salt buffer (100mM NaCl, 10mM MgCl2, 1mM DTT, 20mM 
HEPES, pH 7.5), and concentrated to proper concentrations for biochemical 
assay or crystallization using an Amicon concentrator. 
 
Peptides 
        Peptides were synthesized in Dr. Kay’s lab at the Biochemistry department, 
University of Utah. The crude materials were purified by reverse phase C18 





Analytical size exclusion chromatography 
        A Superdex200 column was equilibrated in running buffer (10mM MgCl2, 
100mM NaCl, 20mM HEPES, pH7.0). 1mM ADP·AlFx or ATP was added to the 
running buffer if needed. When there was ADP·AlFx or ATP in the running buffer, 
the nucleotide was added to the Vps4 sample and the sample was incubated at 
4°C overnight before loading onto the column. The column was calibrated by 
protein standards (Biorad), and the predicted positions of the Vps4 dodecamer, 




        Malachite green, which forms a green complex with the free phosphate 
released from ATP hydrolysis, was used to measure the ATPase activity of 
Vps4p. Vps4p or its variants (final concentration 0.3µM) was mixed with 2µM 
ATP in reaction buffer (100mM NaCl, 10mM MgCl2, 1mM DTT, 20mM HEPES, 
pH 7.5). The mixture was incubated for 10min at 37°C. Addition of 2x volume of 
malachite green solution (14 mM ammonium molybdate, 1.3 M HCl, 1.5 mM 
malachite green) was followed by adding the same volume of 21% citric acid to 
stop the reaction. Absorbance at 650nm was measured by a plate reader. The 
concentration of the free phosphate released from ATP hydrolysis was calculated 






        The purified proteins or protein complexes were concentrated to from 
5mg/ml to 15mg/ml. ADP·AlFx was added into proteins or protein complexes to 
1mM. The sitting drop method was used for the initial broad screens. The 
crystallization conditions from eight commercial crystallization screens were used: 
Hampton Crystal Screen HT 1&2, Hampton Index, Hampton Salt, Hampton 
Natrix, Hampton Lite, Jena Bioscience Screen HTS1, Qiagen JCSG+, Qiagen 
PACT. Three different temperatures were tried: 4°C, 13°C, and 20°C. Initial hits 
were optimized by altering the pH, precipitants, concentration of precipitants, 
additives, and centration of additives. 
 
Data collection  
        The diffraction data were collected at our home X-ray source or at a 
synchrotron (SSRL or NSLS). A cryo-protectant that allowed the crystals to 
freeze clear, usually 15-20% glycerol or mineral oil, was added to the drops when 
necessary. Crystals were cooled by plunging into liquid N2 prior to data collection 
at 100K. 
 
Data analysis  
        Collected data were indexed by d*TREK 25 or DENZO 26. The possible 
number of molecules in each asymmetric unit and the corresponding solvent 
content was determined by Matthew’s Probability Calculator 
(http://www.ruppweb.org/mattprob/). If a complete data set was collected, the 
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data were scaled by SCALEPACK 26. Self-rotation functions were calculated 
using 27. To determine whether a crystal contains a hexamer, two criteria were 
set. First, a 6-fold noncrystallographic or crystallographic symmetry was 
expected. If the data allowed calculation of a self-rotation function, it was 
inspected for the presence of a 6-fold symmetry peak, although we were 
cognizant of the potential for an asymmetric hexamer to give only weak or no 
signal by this criterion.  Crystallographic symmetry was considered to determine 
if it might be coincident with the axis of a Vps4 hexamer. For example, if the 
crystal contains one molecule in each asymmetric unit, there must be a 6-fold 
crystallographic symmetry, and the 6-fold symmetric axis cannot be a screw axis. 
If there are two molecules in each asymmetric unit, there must be a 3-fold 
crystallographic symmetry. If there are three molecules in each asymmetric unit, 
there must be a 2-fold crystallographic symmetry. Another fundamental criterion 
is that the unit cell must be big enough to accommodate a p97-like Vps4 
hexamer 1; 6. To accommodate the p97-like hexamer model, the length of two of 
three edges of a unit cell must be larger than 130Å (Figure 3.1). For the crystal of 
the Vps4:peptide complex, the extra very convenient criterion is that the crystal 
must be green since the peptide contains a fluorescein. 
 
 




        The structure of one crystal form of Sulfolobus solfataricus Vps4 was solved 
by SAD-MR. SAD data were collected on a Sel-Met crystal of Sulfolobus 
solfataricus Vps4. SHELX 28 was used to phase the data to get the initial electron 
density map. Molecular replacement was applied to search the Sulfolobus 
solfataricus Vps4 monomer model in the electron density map by Molrep 29. 
 
Results 
Crystallization of Crenarchaeal Vps4 homologs 
        Twelve different Vps4 homologs from different Crenarchaeal species were 
cloned, expressed, and purified. For those homologs that purified as a soluble 
protein, oligomerization was tested in the absence or presence of ATP by 
analytical size-exclusion chromatography (Table 3.2). The oligomerization of 
Vps4 homologs from Sulfolobus solfataricus, Sulfolobus tokodaii, and Acidianus 
hospitalis was confirmed by analytical ultracentrifugation. 
        The Vps4 homologs from Sulfolobus solfataricus, Sulfolobus tokodaii, 
Sulfolobus acidocaldarius, Acidianus hospitalis, Ignicoccus hospitalis, 
Ignisphaera aggregans, Acidilobus saccharovorans, Thermosphaera aggregans, 
Desulfurococcus kamchatkensis were subjected to crystallization trials with and 
without ADP·AlFx . Initial hits were optimized and screened (Table 3.3). Two 
structures of the AAA+ ATPase cassette from Sulfolobus solfataricus and 




Table 3.2. Oligomerization of Crenarchaeal Vps4 homologs  
 
         
        One crystal from Sulfolobus solfataricus Vps4(E206Q) in the presence of 
ADP·AlFx (the first crystal form on Table 3.3) was a good candidate to contain a 
p97-like Vps4 hexamer based on its self-rotation function (Figure 3.2 A). The six-
fold noncrystallographic symmetry revealed by the self-rotation function indicates 
there might be a hexamer in the crystal. Optimization efforts on this crystal form, 
including trying different concentrations of precipitant, different precipitants, 
different pH, different concentration of additives, different additives and surface 
entropy reduction mutants, did not result in a crystal with resolution higher than 
4Å. The structure was solved by SAD-MR. The initial map was calculated by 
SAD, and then molecular replacement was applied using the structure of 
Sulfolobus solfataricus Vps4 as the search model. Two Vps4 monomers were 
found in each asymmetric unit according to the SAD-MR solution (Figure 3.2 C), 
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Figure 3.2. Analysis of a crystal form of Sulfolobus solfataricus Vps4. 
A: Observed self-rotation function of the diffraction data set collected from the 
crystal. There is a 6-fold noncrystallographic symmetric axis parallel to the edge 
a of the unit cell and 6 2-fold symmetric axes perpendicular to the 6-fold 
symmetric axis. B: Calculated self-rotation function of the solution model, which 
is similar to the observed self-rotation function. C: Molecular replacement 
solution of this crystal form. Two monomers in one symmetric unit were colored 
yellow and orange. D: No hexamer can be formed when crystallographic 
symmetry was applied. E. Every Se atom in the substructure is close to a 




and the solution was validated by the positions of selenium atoms in a heavy 
atom derivative, which were very close to methionine residues in the solution 
model (Figure 3.2 E) and that the calculated self-rotation function of the solution 
model was very similar to the self-rotation function of the collected data (Figure 
3.2 A, B). Unfortunately, however, the crystal lattice did not generate a hexamer 
(Figure 3.2 D). 
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Co-crystallization of Vps4p:VSL complex 
        The C-terminal VSL domain of Vta1p has been shown to stimulate the 
ATPase activity of Vps4 and to stabilize Vps4 oligomer 18; 19. To co-crystallize 
Vps4p with the VSL domain, the VSL domain was expressed in E. coli and 
purified. Figure 3.3 indicates that the purified VSL domain can stabilize a Vps4 
hexamer.  
         VSL domain was copurified with ΔMIT-Vps4p by size-exclusion 
chromatography in the presence of ADP∙AlFx. The purified samples were 
analyzed by SDS-PAGE electrophoresis. VSL domain can be copurified with 
ΔMIT-Vps4p as a complex (Figure 3.4). The Vps4p-VSL complex was collected 
and concentrated to 10m/ml. Crystallization of the concentrated sample led to 
several hits. Two of them could be characterized after optimization. Unfortunately, 
however, neither of them contains a Vps4p hexamer (Table 3.4). 
 
 





Figure 3.4. Purification of Vps4p:VSL complex. 
ΔMIT-Vps4p was mixed with Vta1p VSL with a ratio of 6:3 and was loaded onto 
the SD200 column equilibrated with ADP·AlFx buffer. There are two peaks on the 
chromatogram. Analysis with SDS-PAGE electrophoresis indicated that peak1 is 














Crystallization of templated Vps4 hexamer 
        To stabilize the Vps4 hexamer, a template molecule that exists as a highly 
stable hexamer was fused to the C-terminus of the Vps4p AAA+ ATPase domain. 
CCMK4, which can form stable hexamer in vitro 21 and has been used as the 
template for crystallizing HIV CA protein hexamer 22, was chosen as the template 
to be fused to the C-terminus of the Vps4p AAA+ ATPase cassette. Guided by 
the CCMK4 crystal structure and p97 D1 homology model, a (G4S)3 linker was 
inserted between Vps4p and CCMK4. Analytical size-exclusion chromatography 
was used to demonstrate that the fused protein is a stable oligomer in the 
absence of nucleotide (Figure 3.5 B). To test whether the fusion protein can form 
the properly assembled Vps4 hexamer, the ATPase activity of the fusion protein 
was used as the indicator because the ATPase activity required assembled Vps4. 
Without the MIT domain and the whole linker region between the MIT domain 
and the AAA+ ATPase cassette, the Vps4p AAA+ ATPase domain alone cannot 
hydrolyze ATP by itself, and adding VSL domain can activate the ATPase activity 




Figure 3.5. Vps4p-CCMK4 oligomerized properly. 
A: ATPase activity of Vps4p-AAA+ ATPase cassette and the Vps4p-CCMK4 
fusion protein. Vps4p(122-437)-CCMK4 can hydrolyze ATP, and the activity can 
be boosted by VSL domain of Vta1p. B: Analysis of the oligomerization of Vps4p-
CCMK4 by analytical size-exclusion chromatography. The dotted line indicates 




Vps4 oligomer. When the AAA+ ATPase cassette was fused to the N-terminus of 
CCMK4, ATPase activity was observed (Figure 3.5 A). The ATPase activity of 
the fusion protein can be further enhanced by adding VSL (Figure 3.5 A). This 
indicated that the Vps4p AAA+ ATPase cassette can oligomerize properly when 




      Two fusion proteins were generated with this template: Vps4p(101-437)-
CCMK4 and Vps4p(122-437)-CCMK4. The fusion protein was crystallized 
together with the VSL domain. Two crystal hits grew about one month after the 
crystallization trays were set up (Table 3.5). However, neither of them contained 
a unit cell big enough to hold p97-like Vps4 hexamer (Table 3.5). 
 
Crystallization of Vps4p:substrate complex 
        The peptide corresponding to helix5 of Vps2, an ESCRT-III subunit from 
Saccharomyces cerevisiae, bound to the pore loops of Vps4p hexamer (Figure 
3.6 A, C and Chapter 4). A construct of ΔMIT-Vps4p carrying pore loop mutations 
E243A and E247A was found to interact with the peptide with much higher 
affinity than wild type ΔMIT-Vps4p (Figure 3.6 B, C and Chapter 4). The peptide 
was used in co-crystallization trials with wild type ΔMIT-Vps4p and ΔMIT-
Vps4p(E243A, E247A) in the presence of VSL and ADP·AlFx . Several crystal 
hits were obtained, optimized, and screened. Some of these crystal diffracted to 
better than 10Å resolution and were indexed and analyzed.  Unfortunately, none 
of these hits contained a Vps4p hexamer (Table 3.6). Several hits had very low  
 






Figure 3.6. Peptide corresponding to the predicted helix 5 of Vps2 binds to Vps4p 
hexamer. 
A: Sequence of the peptide. A fluorescein molecule is attached to the N-terminus 
of the peptide. B: Important residues on pore loop 2. A p97-like Vps4p hexamer 
was shown on the left. Pore loop 2 is colored green and pore loop 1 is colored 
orange. Alanine replacement on E243 and E247 (shown as sticks) increased the 
affinity between Vps4p hexamer and the peptide. C: The ∆MIT-Vps4p hexamer 
can bind to the peptide. Pore loop 2 mutations E243A and E247 can increase the 
binding affinity. 
 













resolution and did not give useable data, but did display a green color, which 
indicated that they might contain Vps4p:peptide complex. 
 
Discussion 
         Although Vps4 forms an oligomer in solution in the presence of ATP or ATP 
analogs, crystallization of Vps4 proteins from different species always resulted in 
Vps4 monomers packed in the crystals like a spiral 6; 30. The crystallographic 
interface between two monomers along one spiral is conserved among all of the 
published crystal forms of Vps4 1; 6; 7; 8; 9; 30.  
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        The conserved crystallographic interface is similar to the hexameric 
interface in the p97-like hexamer model of Vps4 6; 30. One possible reason why a 
hexamer cannot be crystallized is that the hexamer is asymmetric, and the 
previous crystallization efforts did not start with a stable asymmetric hexamer.  
        To stabilize the asymmetric hexamer, the ATP analog ADP·AlFx, which can 
mimic different states of ATP during ATP hydrolysis, were used. Stable hexamer 
can be obtained in the solution with ADP·AlFx, but high resolution crystals 
containing Vps4 hexamer were not obtained. Another method used to stabilize 
the asymmetric hexamer was to form a complex with a peptide substrate (see 
Chapter 4). Crystallization efforts with the currently used peptide have not yet led 
to high resolution crystals containing Vps4 hexamer. Efforts to create new 
peptides which have higher affinity to Vps4 hexamer should be one of the future 
directions. Peptide with higher affinity might be obtained by introducing mutations 
to the current peptide, which will be better crystallization partners for Vps4 
hexamer. At the same time, more constructs of Vps4p with different truncations 
on the N-terminus or with surface entropy reduction mutations should also be 
made to be co-crystallized together with the peptide. 
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CHAPTER 4  
 
ESCRT-III HELIX 5 BINDS THE VPS4 HEXAMER CENTRAL  
PORE IN AN INTERACTION THAT IS AUTOINHIBITED  




        Vps4 is a hexameric AAA ATPase that functions with the ESCRT-III 
complex to drive reverse topology membrane fission events during several 
cellular processes, including cytokinesis, MVB biogenesis, and HIV budding. 
Vps4 contains an N-terminal MIT domain that binds the C-terminal MIM motifs of 
ESCRT-III subunits, although it is not known how the mechanism progresses 
from this initial recognition to ATP-driven disassembly of ESCRT-III complexes.  
Here, we report that Vps4p lacking the MIT domain can form a hexamer that 
binds residues from helix 5 of the Vps2p/ESCRT-III subunit.  Mutagenesis 
experiments map this interaction to the central pore of the Vps4p hexamer, and 
the observed 6:1 Vps4p:Vps2p binding stoichiometry indicates that the functional 
Vps4p hexamer is asymmetric.  These data support a model that the ESCRT-III 
complexes are disassembled by pulling the helix 5 of ESCRT-III through/into the 
central pore of Vps4 hexamer.  Our finding that a sequence preceding Vps2p 
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helix 5 does not bind the Vps4p pore suggests that “stop translocation” 
sequences regulate the extent to which substrates pass through the Vps4p pore.  
We also report that binding of the Vps2p/ESCRT-III peptide is autoinhibited by 
the MIT domain of full-length Vps4p, and that this inhibition is alleviated when the 
MIT engages a MIM motif, thereby indicating a mechanism to ensure specificity 




        The cellular Endosomal Sorting Complexes Required for Transport (ESCRT) 
pathway functions in reverse topology membrane fission events, including the 
sorting of ubiquitylated cargo proteins into multivesicular bodies (MVB) 1; 2; 3; 4; 5, 
the abscission step of cytokinesis 6; 7, and the budding of many retroviruses, 
including HIV budding 8; 9; 10; 11; 12.  It comprises multiple protein complexes: 
ESCRT-0, I, II, III, and the Vps4 complex; plus a number of accessory proteins 13; 
14. ESCRT complexes are recruited sequentially to the site of membrane fission 
13; 14; 15; 16.  ESCRT-0 functions in ubiquitylated cargo sorting, and ESCRT-I & II 
drive membrane deformation.  When ESCRT-III proteins are recruited to the 
membrane, they form a lattice structure that is thought to constrict the membrane 
neck 3. The AAA ATPase Vps4 is then recruited to the membrane neck before 
fission occurs, and it subsequently disassembles the ESCRT-III lattice 16; 17; 18; 19; 
20. ESCRT-III complexes can be disassembled by Vps4 in vitro 20, although the 
mechanism of ESCRT-III disassembly by Vps4 is not yet established. 
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        Vps4 includes an N-terminal MIT domain that forms a three helices bundle 
that serves as the primary substrate recognition module by binding the C-
terminal MIT-Interacting Motifs (MIMs) of ESCRT-III subunits 21; 22; 23; 24. There 
are seven members (Vps2p0, Snf7, Vps2p4, Vps2p0, Did2, Vps60, and Ist1) of 
the ESCRT-III family in S. cerevisiae 14, three of which (Vps2p, Did2, and Ist1) 
contain MIM motifs that interact directly with Vps4 24; 25. Two different types of 
Vps4-interacting MIM (MIM1 and MIM2) have been characterized, including 
structures of MIM1:MIT and MIM2:MIT complexes 21; 23; 24. Only MIM1 has been 
identified in the ESCRT-III subunits from S. cerevisiae 24; 25.  Structures of the 
CHMP3(hVp24) and Ist1 subunits show that the different ESCRT-III family 
members display a conserved four helices core domain followed by unstructured 
sequences and at least two additional helices 26; 27; 28. The four helices core 
appears to mediate ESCRT-III lattice formation, while the 5th α-helix can bind to 
the core domain to stabilize the soluble unassembled state and inhibit lattice 
formation 26.  
        The Vps4 MIT domain is followed by a ~40-residue linker and a single AAA+ 
ATPase cassette that is responsible for ATP hydrolysis, oligomerization, and 
presumably substrate (ESCRT-III proteins) processing 1; 29; 30; 31. Multiple crystal 
structures of Vps4 ATPase cassettes in the monomeric state have been reported 
30; 31; 32; 33; 34. Although the subunit stoichiometry of the active Vps4 ATPase has 
been controversial 32; 35; 36, we have recently shown that Vps4, like most 
characterized AAA+ ATPases 37; 38,  functions as a hexameric ring (see Chapter 
2). Our working model for the Vps4 hexamer is based on the structure of the p97 
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D1 ATPase cassette hexamer, and is supported by mutational analysis of 
proposed hexamer interface residues 30; 31; 39. This model features two pore loops: 
pore loop 1 and pore loop 2 that, similar to other AAA+ ATPases, line the central 
pore of the hexamer 30; 31; 39.  Pore loops of AAA+ ATPase hexamers form the 
substrate binding/processing motifs, as demonstrated for the unfoldase ClpX and 
the papillomavirus E1 helicase 40; 41; 42; 43. Pore loop 1 of Vps4 displays an Ar-Φ 
loop that includes an aromatic residue followed by a hydrophobic residue, which 
is conserved among many AAA+ ATPases that have polypeptide substrates 30, 
and has been shown to be able to grip the substrate in Clpx and spastin 40; 44.  
Mutations on both pore loops of Vps4 have been shown to restrict HIV-1 budding 
30; 31. 
          Motivated by observations that C-terminal fragments of overexpressed 
ESCRT-III subunits CHMP2A and CHMP1B are required for their co-
sedimentation with VPS4B_E235Q from cell lysate 45 and that C-terminal 
fragments of ESCRT-III proteins activate the ATP hydrolysis activity of VPS4A 46, 
we characterized the Vps4-ESCRT-III interaction using purified recombinant 
yeast proteins Vps4p and Vps2p, which is the yeast homolog of CHMP2.  We 
found that the AAA+ ATPase cassette of Vps4p can form a stable hexamer with 
the nonhydrolyzable ATP analogs ADP·AlFx or ADP·BeFx and the VSL domain of 
the Vta1p cofactor, and that this hexameric complex directly binds a single 
peptide of Vps2p helix 5 in an interaction that is mediated by the Vps4p pore loop 
residues.  Moreover, we found that binding of the α-helix 5 of Vps2p to the 
ATPase domain was autoinhibited by the MIT domain, and that this inhibition is 
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alleviated by MIM-MIT interaction. These observations support the model that 
ESCRT-III complexes are disassembled by pulling the helix 5 of ESCRT-III 
through or into the central pore of the Vps4p hexamer in a manner that is initially 
primed and activated by binding of MIT domains to ESCRT-III MIM sequences. 
 
Materials and methods 
Cloning   
        DNA encoding full-length Vps4p, full-length Vps2p, and full-length Vta1p 
was cloned into the E.coli expression vector pET151 as described previously 30; 
31; 36. The mutations or deletions were introduced into pET151-Vps4p, pET151-
Vps2p, and pET151-Vta1p constructs by Quikchange mutagenesis and verified 
by DNA sequencing.  
 
Peptides and proteins 
        Peptides were synthesized in Dr. Kay’s lab at the Biochemistry department, 
University of Utah. The crude materials were purified by reverse phase C18 
HPLC and the mass was confirmed by mass spectrometry (MS) at the University 
of Utah Peptide Synthesis Core. 
        Vps4p and Vta1p proteins were purified as described 30; 31; 36.  Briefly, 
proteins were expressed in BL21 RIL codon+ E.coli cells in ZY autoinduction 
media at 37°C until OD600 of 0.5 and then overnight at 21°C.  Cells were 
harvested by centrifugation and lysed by incubation with 10 mg/ml lysozyme in 
lysis buffer (20mM imidazole, 300mM NaCl, 25mM Tris, pH 7.5, and protease 
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inhibitors including PMSF, aprotinin, leupeptin, pepstatin) at 4°C for 1 hour, 
followed by sonication.  Cell lysates were clarified by centrifugation at 35,000 g 
for 45min, and the supernatant was incubated with Ni-NTA agarose for 1 hour 
and then washed with at least 10x volume of lysis buffer.  For Vps2p proteins, the 
Ni-NTA wash was performed in high salt buffer (20mM imidazole, 1M NaCl, 
25mM Tris, pH 7.5, and protease inhibitors including PMSF, aprotinin, leupeptin, 
pepstatin).  Protein was eluted with elution buffer (400mM imidazole, 300mM 
NaCl, 25mM Tris, pH 7.5), and incubated with TEV protease (~1mg/100mg) in 
cleavage buffer (150mM NaCl, 1mM EDTA, 1mM DTT, 25mM Tris, pH 7.5) for 20 
hours at 4°C followed by passage through a Ni-NTA agarose column to remove 
the cleaved affinity tag and unprocessed proteins. For Vps4p and Vta1p proteins, 
a subsequent Q chromatography step was applied. Specifically, Vps4p in buffer 
A (100mM NaCl, 20mM HEPES, pH 7.5) was loaded onto a HiTrap Q HP (GE 
Healthcare Life Sciences). The column was washed with 5x volume of buffer A. 
Then the protein was eluted with a gradient (0-35%) of buffer B (1M NaCl, 20mM 
HEPES, pH 7.5). Purified proteins were dialyzed into low salt buffer (100mM 
NaCl, 10mM MgCl2, 1mM DTT, 20mM HEPES, pH 7.5) for biochemical 
experiments. 
 
Analytical size-exclusion chromatography 
        A superdex200 column was equilibrated in running buffer (2mM ADP·AlFx or 
ADP·BeFx 10mM MgCl2, 100mM NaCl, 20mM HEPES, pH7.0). Vps4p or its 
variants were preincubated with Vta1p-VSL in running buffer at 4°C for at least 2 
85 
 
hours. The samples were filtered before being loaded onto the column. The 
column was calibrated by protein standards (Biorad). 
 
Fluorescence anisotropy 
        A series of different concentrations of Vps4p (or its variants):Vta1p-VSL 
complexes were incubated with peptides (1nM) at 25°C for at least 3 hours. The 
fluorescence anisotropy value was measured at 25°C. The binding affinity was 
obtained by fitting the data to a 1:1 interaction model using GraphPad Prism5. 
 
GST pull-down assay 
        Purified ∆MIT-Vps4p or full-length Vps4p (240 µM) and GST fusion proteins 
(40µM) were mixed with or without ADP·AlFx.  A 50 µl portion of glutathione 
agarose (Amersham) was preincubated with the protein samples for 2 hours at 
4°C. Unbound proteins were removed by washing with wash buffer (10mM MgCl2, 
100mM NaCl, 20mM HEPES, pH7.0) containing 2mM ADP·AlFx or not. Bound 




        Malachite green, which forms a green complex with free phosphate 
released upon ATP hydrolysis, was used to measure the ATPase activity of 
Vps4p. Full-length Vps4p:Vta1p-VSL complex (final concentration 0.15µM) or 
∆MIT-Vps4p:Vta1p-VSL complex (final concentration 0.3µM) was mixed with 
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2µM ATP in reaction buffer (100mM NaCl, 10mM MgCl2, 1mM DTT, 20mM 
HEPES, pH 7.5). Peptides or Vps2p were added as indicated.  The mixture was 
incubated for 10min at 37 4°C.  Then 2 volumes of malachite green solution (14 
mM ammonium molybdate, 1.3 M HCl, 1.5 mM malachite green) were added into 
the reaction, followed by adding 21% citric acid of the same volume of malachite 
green solution.  Absorbance at 650nm was measured using a plate reader. The 
concentration of the free phosphate released from ATP hydrolysis was calculated 
according to a sodium phosphate standard. 
 
Results 
Vps2p peptides bind the ATPase cassette  
of an asymmetric Vps4p hexamer 
        To determine if Vps2p/ESCRT-III sequences preceding the MIM motif 
directly contact the Vps4p ATPase cassette, we used a Vps4p construct that 
lacks the N-terminal MIT domain in a fluorescence anisotropy assay with two 
overlapping fluorescein-labeled peptides, peptide A and peptide B, and peptide C 
corresponding to the sequence shared between peptides A and B (Figure 4.1).  
Although the full-length Vps4p hexamer exists as a concentration-dependent 
equilibrium of dimers and hexamers (Chapter 2), we found that ΔMIT-Vps4p (81-
437) in complex with the VSL domain of Vta1p formed a stable hexamer in the 
presence of ADP·AlFx or ADP·BeFx over the concentration range used for the 
titration experiment (Figure 4.1).  An interaction was observed in the presence of 
ADP·AlFx or ADP·BeFx, but not ATP, ADP, AMPPNP, or ATPγS (Figure 4.1). The  
87 
 
Figure 4.1. Vps2p helix 5 binds the Vps4p cassette. 
A: Sequence alignment of helix 5 and nearby loops from ESCRT-III proteins. 
Peptides A, B, C were labeled with an N-terminal fluorescein. Peptides A2, B2, 
and C2 were labeled on the C-terminus. The acidic residues patch is indicated by 
a red rectangle.   
B: Peptides A, B, and C bind to ∆MIT-Vps4p in the presence of ADP·AlFx or 
ADP·BeFx  but not in the presence of other nucleotides tested.  
C: ∆MIT-Vps4p forms a stable hexamer in the presence of Vta1p-VSL and 
ADP·AlFx or ADP·BeFx. ∆MIT-Vps4p at 200 M (solid) and 50 M (dotted) was 
run on a gel-filtration column in the presence of Vta1p-VSL and different 
nucleotides. Virtical dotted lines indicate calculated elution volume of the ∆MIT-














failure to detect binding with ATP is consistent with transient interactions in the 
presence of productive substrate cycling.  The ability of ADP·AlFx and ADP·BeFx 
to support binding may reflect their ability to mimic multiple states, including ATP, 
ADP, and transition state bound nucleotide complexes, and a requirement for 
different subunits of the Vps4p hexamer to adopt different conformation to 
generate an asymmetric substrate binding surface. 
         The binding affinity between the ΔMIT-Vps4p:Vta1p-VSL hexamer and the 
peptides in the presence of ADP·AlFx was calculated assuming that one Vps4p 
hexamer binds one peptide (below). Peptide A (Kd = 2.5 ± 0.5 μM) bound to the 
Vps4p hexamer more tightly than peptide B (Kd = 6.1 ± 2.4 μM). Peptide C bound 
with the same affinity as peptide A (Kd = 2.4 ± 0.5 μM) (Figure 4.1). The Vps2p 
MIM1 motif (218-232), a negative control that has a similar length to peptide C, 
was found to bind with an affinity 20 times lower than peptide C (Figure 4.1). 
         We also test the interaction between the Vps4p hexamer and the C-
terminally labeled peptides of the same sequences (peptide A2, B2, and C2). 
Peptide A2 and peptide A have similar affinity to Vps4p the hexamer (~2-fold 
difference) (Figure 4.2). However, peptide B2 and C2 have much lower affinity (> 
5-fold) towards Vps4p hexamer compared with peptide B and C, respectively 
(Figure 4.2). Peptide B2 and C2 have the fluorescein attached to the same 
residue (Gln184), so this residue or nearby residue(s) may be important for 
interaction with Vps4p hexamer. Atomic details of this interaction are required to 
understand how different residues contribute to the substrate binding to Vps4p 




Figure 4.2. Binding of C-terminally labeled peptides to Vps4p hexamer. 
C-terminally fluorescein labeled peptide A2, B2, and C2 have the same 
sequences as peptide A, B, and C, respectively. Fluorescence anisotropy assay 
was used to measure the binding affinity between the peptides and Vps4p or its 




The Vps4p hexamer binds a single peptide 
        To verify the stoichiometry of this interaction, peptide C of high 
concentration (~20-fold above the Kd) was titrated with ΔMIT-Vps4p hexamers in 
the presence of ADP·AlFx.  Peptide binding was saturated when the 
stoichiometry was close to 1 (Figure 4.3). This is consistent with the model that 
only the asymmetric Vps4p hexamer is capable of forming binding sites for 




Figure 4.3. One ∆MIT-Vps4p hexamer binds one Vps2p-helix 5. 
Fluorescence anisotropy was measured during titration of 50µM (~25-fold of Kd) 
peptide C with the ∆MIT-Vps4p:Vta1p-VSL hexamer.  Saturation of the signal 




formed within one hexamer.  This model is appealing because the AAA ATPases  
E1 helicase 41 and Rho helicase 42 have been visualized binding their DNA and 
RNA substrates in this manner in their central pores.  Other AAA ATPases, 
including ClpX 40, ClpB 47, and spastin 44, also appear to bind their substrate in 
the central hexamer pore, and are therefore also expected to have a 
stoichiometry of one substrate per hexamer. 
 
Pore loop residues are important for  
binding of Vps2p-derived peptides 
        Our working hexamer model positions Vps4p pore loop 1 and pore loop 2 at 
the central pore 30; 31; 39. To determine if residues in these loops contribute to 
binding, we tested peptide binding to pore loop mutants that have been 




correspond to S. cerevisiae Vps4p W206A on pore loop 1, R241A on pore loop 2, 
and R251A adjacent to pore loop 2 30; 31. Consistent with the model, none of 
these point mutants bind peptides with appreciable affinity (Figure 4.4 A). 
         Although these pore loop mutants did not bind to peptide, the hexamer 
stability of these mutants was reduced compared to wild type protein at low 
concentrations (Figure 4.4 B), which raises concern that the effect may be due to 
loss of assembly rather than loss of peptide binding per se.  To find mutations 
that do not destabilize the Vps4p hexamer, we substituted pore loop residues 
with alanine and assayed oligimerization by analytical size exclusion 
chromatography. Out of ten residues tested, three were found not to impair  
 
 
Figure 4.4. A conserved aromatic residue on pore loop 1 and both Arg residues 
on pore loop 2 of Vps4p hexamer are crucial for binding Vps2p-helix 5. 
A: ∆MIT-Vps4p carrying a single mutation of these residues cannot bind the 
Vps2p-derived peptide. 
B: Mutant ∆MIT-Vps4p cannot form stable hexamers compared to wild type 





 oligomerization: T240 (pore loop 2), E243 (pore loop 2), and E247 (pore loop 2) 
(Figure 4.5A).  Additional mutations at these positions were therefore made and 
tested for peptide binding.  Of particular interest, the T240K, E243A, and E247A 
variants increased the binding affinity to Vps2p-helix 5 derived peptideC by 2-, 3-, 
and 4-fold, respectively (Figure 4.5). The double mutant, ∆MIT-Vps4p (E243A, 
E247A) bound 5-fold (peptide C) or 10-fold (peptide B) more tightly than wild type 
Vps4p (Figure 4.5).  Because several different mutations on the pore loops of 
Vps4p can increase or reduce peptide binding affinity without apparently 
changing the hexamerization state, we conclude that the Vps4p substrates bind 
to the pore loops. 
 
Charge-charge repulsion limits the Vps4p-Vps2p interaction 
        Peptide B, but not peptide C, displays a larger fluorescence anisotropy 
value when bound to ΔMIT-Vps4p (E243A, E247A) than wild type ΔMIT-Vps4p 
(Figure 4.5). This implies that the peptide B fluorophore tumbles more slowly 
when bound to ΔMIT-Vps4p (E243A, E247A) than wild type ΔMIT-Vps4p, and 
suggests that the fluorophore is closer to the ΔMIT-Vps4p (E243A, E247A) 
binding site than to the wild type ΔMIT-Vps4p binding site. Compared to peptide 
C, peptide B has several additional acidic residues between the N-terminal 
fluorescein and their common binding motif (Figure 4.5). Because the mutated 
Vps4p pore loop residues are also acidic (E243, E247), we propose that the 
charge-charge repulsion between acidic residues of Vps4p pore loop 2 and 
Vps2p helix 5 limits the interaction and cause the N-terminal fluorophore of  
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Figure 4.5 Negatively charged residues on pore loop 2 of the Vps4p hexamer 
regulate binding to Vps2p-helix 5. 
A: ∆MIT-Vps4p hexamer model based on the p97 D1 hexamer structure. Pore 
loops 1 and 2 are highlighted in orange and green, respectively. T240, E243, and 
E247 are shown as sticks. 
B: ∆MIT-Vps4p carrying point mutations T240A, E243A, or E247A on pore loop 2 
can oligomerize into a hexamer in the presence of Vta1p-VSL and ADP·AlFx. 
Oligomerization of ∆MIT-Vps4p at loading concentration of 50µM was measured 
by gel filtration in the presence of Vta1p-VSL and ADP·AlFx. The column was 
calibrated using molecular weight standard proteins. The two dotted lines 
indicate the calculated elution volumes of hexamer and dimer.  
C: ΔMIT-Vps4p or its variants carrying mutations on T240, including T240A, 
T240F, T240K, were tested for binding to peptide C by fluorescence anisotropy 
assay. All of the three mutations can change the binding affinity slightly. 
D: ΔMIT-Vps4p or its variants carrying mutations on E243 and/or E247 were 
tested for binding to peptide B and C by fluorescence anisotropy assay. Double 
mutation E243A+E247A on pore loop 2 can increase both the binding affinity 
between ΔMIT-Vps4p and peptide B and the saturated fluorescence anisotropy 
value of ΔMIT-Vps4p bound peptide B significantly. The fluorescence anisotropy 

















peptide B to be held away from Vps4p.         
         The continuous negatively charged residues preceding helix 5 of Vps2p are 
conserved among several ESCRT-III proteins, including three of the four core 
ESCRT-III proteins: Snf7/CHMP4, Vps24/CHMP3, and Vps2/CHMP2 (Figure 
4.1A). The negatively charged pore loop 2 residues are also conserved between 
S. cerevisiae Vps4p and the two human isoforms, VPS4A and VPS4B (Figure 
4.6A). There are three acidic residues on pore loop 2 for each subunit. Mutation 
on the middle one (E245 on Vps4p) can severely affect the oligomerization of 
Vps4, so only two acidic residues (E243, E247 on Vps4p) can be mutated 
without significantly affect the oligomerization of Vps4. To test the biological 
importance of the negatively charged collar in human cells, we introduced the 
corresponding mutations (E245A, E249A) into VPS4B, and expressed the mutant 
VPS4B in VPS4A/B depleted cells.  Expression of exogenous wild type VPS4B 
or VPS4B with a single collar mutation rescued HIV budding in this context, 
whereas VPS4B carrying double mutations on the pore loop 2 (E245A + E249A) 
led to a ~2-fold reduction in virus titer of the released viruses (compare lane 3 
and lane 8 in Figure 4.6C).  The relatively weak affect (only ~2-fold reduction) 
may be because there is still one more acidic residue kept on pore loop 2 of all of 
the subunits within a Vps4 hexamer. Thus, the negatively charged collar on pore 
loop 2 plays a role in HIV budding.  However, because these corresponding 
mutations also impair the ATPase activity of Vps4p (Figure 4.6D), it is not clear 
whether reduced HIV budding results from impaired regulatory function of pore 




Figure 4.6 The acidic residues of Vps4 pore loop 2 contribute to efficient HIV 
budding. 
A: Acidic residues on pore loop 2 are conserved among Vps4p, VPS4A, and 
VPS4B. 
B: Western blots showing detection of Vps4 and viral proteins in cells and viral 
proteins of the harvested virus from the culture supernatants. (It seems there is 
some difference for the MA protein of the released viruses between lane 3 and 8, 
which support the virus budding is limited. But CA protein did not show difference 
between land 3 and 8) 
C: Infectivity of the harvested virus from the culture supernatants. RNAi depletion 
of endogenous Vps4A/B (lane 2) restrict HIV budding.  Expression of exogenous 
wild type Vps4B rescues HIV budding (lane 3). Expressing an ATPase deficient 
Vps4B mutant did not rescue HIV budding (lane 4). Single residue mutations on 
pore loop 2 (lane 6 and 7) did not impair the function of Vps4B in HIV budding 
process, whereas a double mutation (lane 8) led to ~2-fold reduction in HIV 
budding and virus titer of the culture supernatants. 
D: Mutations of the acidic residues on pore loop 2 of Vps4p impaired the ATPase 
activity of Vps4p. ATPase activities of wild type and mutated ∆MIT-Vps4p in 
complex with the Vta1p-VSL domain were measured at 37°C. Double mutation 
(E243A+E247A) on the negatively charged collar reduced the ATPase activity by 







Peptide binding stimulates ΔMIT-Vps4p ATPase 
activity and stabilizes the hexamer 
        Motivated by a report that the C-terminal portion of ESCRTIII proteins 
covering the MIM motif and helix 5 activates VPS4A ATPase activity 46, we 
determined if the same was true for the much shorter peptide C.  Peptide C at 
different concentrations was added to the ΔMIT-Vps4p:Vta1p-VSL complex, and 
the ATPase activity was measured at 37°C.  As shown in Figure 4.7, adding 
peptide C increased ATPase activity, demonstrating that this short Vps2p-helix 5 
peptide can bind and activate the ATPase cassette of Vps4p. 
        An attractive explanation for this observation is that peptide binding 
stabilizes the ΔMIT-Vps4p hexamer. To test this possibility, we characterized the 
oligomerization of ΔMIT-Vps4p:Vta1p-VSL with or without peptide C by analytical 
gel filtration in the presence of ADP·AlFx at a concentration where the complex 
dissociates, which is closer to the concentration at which ATPase activity is 
assayed.  By itself, ΔMIT-Vps4p:Vta1p-VSL did not elute as a single peak 
corresponding to the hexamer (Figure 4.7B) at a concentration of 10 μM.  
However, when the protein complex was pre-incubated with peptide C, the 
majority of the protein eluted as a single peak corresponding to the hexamer 
(Figure 4.7B). This validates the hypothesis that the activation of ATPase activity 
of ΔMIT-Vps4p by peptide C is due, at least partially, to the stabilization of ΔMIT-





Figure 4.7, Vps2p-helix 5 can activate the ATPase activity of Vps4p and stabilize 
the Vps4p hexamer. 
A: Peptide C can activate the ATPase activity of Vps4p. ATPase activity of the 
∆MIT-Vps4p:Vta1p-VSL complex was measured in the presence of different 
concentrations of peptide C. Adding peptides can increase the ATPase activity of 
Vps4p. 
B: Peptide C can stabilize ∆MIT-Vps4p hexamer. Oligomerization of ∆MIT-Vps4p 
(10µM) was measured by gel-filtration in the presence of Vta1p-VSL (10µM) and 
ADP·AlFx. Blue and black dotted lines are calculated positions of ∆MIT-Vps4p 





ESCRT-III binding to pore loops is inhibited by the  
MIT domain in the absence of a MIM interaction 
        Recruitment of Vps4 to the membrane is mediated by MIT domain binding 
to MIM sequences of ESCRT-III substrates 23; 24. To determine if the MIT domain 
also influences binding of the ESCRT-III helix 5 to the Vps4p pore, we measured 
the binding affinity between the full-length Vps4p and the Vps2p-helix 5 derived 
peptide. The affinity of the interaction between the full-length Vps4p and the 
peptide was ~10 times lower than that between ΔMIT-Vps4p and the peptide 
(Figure 4.8B), indicating that the MIT domain has an inhibitory effect on binding 





Figure 4.8. MIM-MIT regulation of Vps2p-helix 5 binding to the Vps4p AAA+ 
ATPase cassette. 
A: Vps4p constructs were used in the binding experiments.  
B: Full-length Vps4p and MIM1(L225D)-Vps4p binding the Vps2p-helix 5 derived 
peptides with ~10-fold lower Kd than ∆MIT-Vps4p and MIM1-Vps4p. 








Vps2p-helix 5 derived peptide fused to GST has higher affinity to ΔMIT-Vps4p 
than to the full-length Vps4p (Figure 4.9). 
        We subsequently tested whether binding of MIM1 to the MIT domain can 
alleviate the inhibitory effect from the MIT domain. To test this hypothesis, we 
inspected the reported MIM1:MIT structure 24 to design an N-terminal extension 
to full-length Vps4p that encoded the MIM1 motif of Vps2p and a (GGGGS)3 linker 
that was long enough to allow the MIM1-MIT interaction (Figure 4.8A). 
MIM1(L225D)-Vps4p was used as the negative control because this mutation 
disrupts the interaction between MIM1 and MIT 24.  The MIM1-Vps4p fusion 
protein bound peptide C ~10 times more tightly than full-length Vps4p, while the 
binding affinity of MIM1(L225D)-Vps4p towards peptide was similar to the affinity 
of full-length Vps4p (Figure 4.8B). GST-pull down assay also confirms that MIM-
Vps4p had similar GST-peptide binding affinity to that of ΔMIT-Vps4p, which was 
much higher than that of the full length Vps4p. This supports the model that 
binding of MIM1 to the MIT domain alleviates the inhibitory effect on substrate 
engagement in the Vps4p hexamer pore. 
        I also tried to determine the mechanism of the regulation of peptide binding 
by the MIT domain and MIM1 motif. One possibility is that the MIT domain has a 
negative impact on the oligomerization of Vps4p that can be alleviated by the 
MIT-MIM1 interaction.  Arguing against this possibility, however, the size of the 
MIM1-Vps4p and MIM1(L225D)-Vps4p oligomers showed no significant 





Figure 4.9. GST-peptide A can bind ∆MIT-Vps4p and full-length Vps4p in the 
presence of ADP·AlFx as demonstrated by pull-down assay. With equivalent 






        Motivated by reports that co-sedimentation of Vps4B(E235Q) with 
overexpressed ∆MIM-CHMP2A is dependent on helix 5 and nearby loops of 
CHMP2A 45, and that C-terminal sequences of ESCRT-III proteins covering helix 
4, helix 5, and C-terminal MIM, activate the ATPase activity of Vps4A 46, we 
mapped this interaction using S. cerevisiae Vps4p and Vps2p (homolog of 
human CHMP2).  Using fluorescence anisotropy, we found that a 20-residue 
peptide derived from Vps2p-helix 5 binds the Vps4p ATPase cassette with the 
same affinity as a longer 28-residue construct.  This peptide also stimulates 
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ATPase activity, at least in part by stabilizing the Vps4p hexamer.  Mutagenesis 
data indicate that the peptide directly contacts that Vps4p pore loops.  We further 
demonstrated that this interaction is regulated by the MIT domain and its 
interaction with the Vps2p MIM residues. These observations support a model 
that ESCRT-III complexes are disassembled by pulling the helix 5 of ESCRT-III 
through/into the central pore of the Vps4 hexamer in a manner that is initially 
primed and activated by binding of MIT domains to ESCRT-III MIM sequences. 
        There are 12 different ESCRT-III proteins in human cells and 7 different 
ESCRT-III proteins in S. cerevisiae. In addition to CHMP2A (hVps2p), C-terminal 
sections of overexpressed ESCRT-III subunits CHMP1B are also important for its 
co-sedimentation with VPS4B_E235Q from cell lysate 45. The C-terminal 
fragments of several different ESCRT-III proteins, including CHMP2A, CHMP1B, 
CHMP3, CHMP4A, CHMP6, and CHMP5, can activate the ATP hydrolysis 
activity of Vps4A 46. We therefore propose that other ESCRT-III subunits make 
equivalent interactions with Vps4 through analogous interactions to those of helix 
5 of Vps2p.  
        The interaction between ΔMIT-Vps4p and Vps2p-helix 5 was dependent 
upon the presence of ADP·AlFx or ADP·BeFx, which are nonhydrolyzable ATP 
analogs that can mimic binding of ATP, ADP, and the transition state. Because 
the interaction was not observed in the presence of other nonhydrolyzable ATP 
analogs, ATP, ADP, or an ATP/ADP mixture, we conclude that cycling ATP 
induces transient interactions, consistent with substrate cycling, and that the 
functional Vps4p hexamer is asymmetric with a requirement for different 
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nucleotide bound conformations at different subunits.  This is consistent with 
models of other ring-like ATPases, including the F1 ATPase 48, the E1 helicase 41 
and the Rho helicase 42, in which crystal structures have demonstrated different 
nucleotide states correlating with subunit pore loop conformations and binding in 
the central pore. 
        Many AAA+ ATPases that process polypeptide substrates display an 
aromatic residue followed by a hydrophobic residue on pore loop 1 30.  This Ar-Φ 
motif has been shown to grip the substrate in Clpx and spastin 40; 44. Vps4 also 
contains this conserved Ar-Φ loop on pore loop 1 (Figure 4.6A).  Mutation of this 
aromatic residue of human Vps4 homologs (W201 of VPS4A and W208 of 
VPS4B) inhibits HIV-1 release 30.  Consistent with this model, we found that 
Vps4p carrying the mutation on the corresponding aromatic residue (W206A) of 
S. cerevisiae cannot bind to Vps2p-helix 5 (Figure 4.4).  A caveat, however, is 
that the Vps4p(W206A) hexamer was not as stable as the wild type hexamer 
(Figure 4.4), which raised the possibility that failure of Vps4p(W206A) to bind 
Vps2p-helix 5 was indirectly due to weaker assembly.  Thus, while the model that 
Vps4 pore loop 1 contacts substrate directly is very attractive, more evidence is 
needed to provide definite confirmation. 
        Vps4 displays three conserved acidic residues on pore loop 2 and the 
downstream helix that form an acidic collar (Figure 4.5). We found that alanine 
substitution on two of these three acidic residues (E243A, E247A) increases 
binding affinity between Vps4p and peptides derived from Vps2p, further 
supporting the model that pore loop 2 is a binding site for Vps2p-helix 5 (Figure 
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4.5). Peptide B contained an extra continuous acidic-residue-patch preceding 
helix 5 compared with peptide C (Figure 4.1A), suggesting that repulsion 
between the acidic-residue-patch preceding helix 5 and the acidic residues on 
pore loop 2 (E243, E247) prevent the Vps4p hexamer binding to the upstream 
sequence of helix 5. Thus, Vps4p pore loop 2 functions in both substrate binding 
and the regulation of substrate binding. 
        Our findings that the MIT domain inhibits peptide binding to the central pore 
and that this inhibition is alleviated by binding of an MIM sequence suggests a 
mechanism to prevent nonspecific substrate binding and processing. Because 
the sequences of ESCRT-III subunits are not conserved, it is likely that the 
Vps4p central pore is able to bind and translocate a wide variety of peptides, but 
the requirement for prior binding of an MIM will exclude engagement of 
inappropriate substrates. 
        Our data support a two-step model of Vps4-mediated ESCRT-III lattice 
disassembly (Figure 4.10). Before interacting with ESCRT-III, the Vps4 hexamer 
central pore has low binding affinity to peptides because of autoinhibition by the 
MIT domain. Following recruitment of Vps4 to the membrane neck by MIT-MIM 
interaction, the substrate-binding potential of the Vps4 pore loops will be 
unmasked, leading to engagement of ESCRT-III helix 5.  We further speculate 
that ESCRT-III lattice disassembly results when the C-terminal region of ESCRT-
III is translocated into the central Vps4 pore, and that the negatively charged 
collar of pore loop 2 prevents passage of ESCRT-III beyond the acidic-residue-








        Important future goals include determining a structure of a Vps4-substrate 
complex in order to visualize molecular details of the Vps4 hexamer assembly 
and pore loop-substrate interaction. Another important goal is to understand the 
MIT domain interactions that inhibit substrate binding and how they are alleviated 
by MIM binding.  Additionally, more data are needed to verify the extent to which 
ESCRT-III translocates through the central pore, and how this is coupled to 
disassembly of the ESCRT-III lattice.  Finally, it is important to explore the extent 
to which this mechanism is conserved. The C-terminal region of several different 
ESCRT-III proteins have been shown to activate the ATPase activity of Vps4 46. 
Sequences of helix 5 from different ESCRT-III subunits are not very well 
conserved, but several ESCRT-III subunits contain the patch of acidic residues 
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N-terminal to helix 5 (Figure 2A).  Systematic work to find out which ESCRT-III 
subunits use this strategy to interact with Vps4 will be important.  
 
References 
1. Babst, M., Sato, T. K., Banta, L. M. & Emr, S. D. (1997). Endosomal 
transport function in yeast requires a novel AAA-type ATPase, Vps4p. 
EMBO J 16, 1820-31. 
 
2. Katzmann, D. J., Babst, M. & Emr, S. D. (2001). Ubiquitin-dependent 
sorting into the multivesicular body pathway requires the function of a 
conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145-55. 
 
3. Babst, M., Katzmann, D. J., Estepa-Sabal, E. J., Meerloo, T. & Emr, S. D. 
(2002). Escrt-III: an endosome-associated heterooligomeric protein 
complex required for mvb sorting. Dev Cell 3, 271-82. 
 
4. Babst, M., Katzmann, D. J., Snyder, W. B., Wendland, B. & Emr, S. D. 
(2002). Endosome-associated complex, ESCRT-II, recruits transport 
machinery for protein sorting at the multivesicular body. Dev Cell 3, 283-9. 
 
5. Katzmann, D. J., Stefan, C. J., Babst, M. & Emr, S. D. (2003). Vps27 
recruits ESCRT machinery to endosomes during MVB sorting. J Cell Biol 
162, 413-23. 
 
6. Carlton, J. G. & Martin-Serrano, J. (2007). Parallels between cytokinesis 
and retroviral budding: a role for the ESCRT machinery. Science 316, 
1908-12. 
 
7. Morita, E., Sandrin, V., Chung, H. Y., Morham, S. G., Gygi, S. P., Rodesch, 
C. K. & Sundquist, W. I. (2007). Human ESCRT and ALIX proteins interact 
with proteins of the midbody and function in cytokinesis. EMBO J 26, 
4215-27. 
 
8. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., 
Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Cote, M., Rich, R. 
L., Myszka, D. G. & Sundquist, W. I. (2001). Tsg101 and the vacuolar 
protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65. 
 
9. Pornillos, O., Higginson, D. S., Stray, K. M., Fisher, R. D., Garrus, J. E., 
Payne, M., He, G. P., Wang, H. E., Morham, S. G. & Sundquist, W. I. 
(2003). HIV Gag mimics the Tsg101-recruiting activity of the human Hrs 
protein. J Cell Biol 162, 425-34. 
108 
 
10. Martin-Serrano, J., Zang, T. & Bieniasz, P. D. (2001). HIV-1 and Ebola 
virus encode small peptide motifs that recruit Tsg101 to sites of particle 
assembly to facilitate egress. Nat Med 7, 1313-9. 
 
11. VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, 
J. & Carter, C. A. (2001). Tsg101, a homologue of ubiquitin-conjugating 
(E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl 
Acad Sci U S A 98, 7724-9. 
 
12. Votteler, J. & Sundquist, W. I. (2013). Virus budding and the ESCRT 
pathway. Cell Host Microbe 14, 232-41. 
 
13. McCullough, J., Colf, L. A. & Sundquist, W. I. (2013). Membrane fission 
reactions of the mammalian ESCRT pathway. Annu Rev Biochem 82, 
663-92. 
 
14. Hanson, P. I. & Cashikar, A. (2012). Multivesicular body morphogenesis. 
Annu Rev Cell Dev Biol 28, 337-62. 
 
15. Wollert, T. & Hurley, J. H. (2010). Molecular mechanism of multivesicular 
body biogenesis by ESCRT complexes. Nature 464, 864-9. 
 
16. Wollert, T., Wunder, C., Lippincott-Schwartz, J. & Hurley, J. H. (2009). 
Membrane scission by the ESCRT-III complex. Nature 458, 172-7. 
 
17. Baumgartel, V., Ivanchenko, S., Dupont, A., Sergeev, M., Wiseman, P. W., 
Krausslich, H. G., Brauchle, C., Muller, B. & Lamb, D. C. (2011). Live-cell 
visualization of dynamics of HIV budding site interactions with an ESCRT 
component. Nat Cell Biol 13, 469-74. 
 
18. Elia, N., Sougrat, R., Spurlin, T. A., Hurley, J. H. & Lippincott-Schwartz, J. 
(2011). Dynamics of endosomal sorting complex required for transport 
(ESCRT) machinery during cytokinesis and its role in abscission. Proc 
Natl Acad Sci U S A 108, 4846-51. 
 
19. Jouvenet, N., Zhadina, M., Bieniasz, P. D. & Simon, S. M. (2011). 
Dynamics of ESCRT protein recruitment during retroviral assembly. Nat 
Cell Biol 13, 394-401. 
 
20. Lata, S., Schoehn, G., Jain, A., Pires, R., Piehler, J., Gottlinger, H. G. & 
Weissenhorn, W. (2008). Helical structures of ESCRT-III are 
disassembled by VPS4. Science 321, 1354-7. 
 
21. Kieffer, C., Skalicky, J. J., Morita, E., De Domenico, I., Ward, D. M., 
Kaplan, J. & Sundquist, W. I. (2008). Two distinct modes of ESCRT-III 
109 
 
recognition are required for VPS4 functions in lysosomal protein targeting 
and HIV-1 budding. Dev Cell 15, 62-73. 
 
22. Scott, A., Gaspar, J., Stuchell-Brereton, M. D., Alam, S. L., Skalicky, J. J. 
& Sundquist, W. I. (2005). Structure and ESCRT-III protein interactions of 
the MIT domain of human VPS4A. Proc Natl Acad Sci U S A 102, 13813-8. 
 
23. Stuchell-Brereton, M. D., Skalicky, J. J., Kieffer, C., Karren, M. A., 
Ghaffarian, S. & Sundquist, W. I. (2007). ESCRT-III recognition by VPS4 
ATPases. Nature 449, 740-4. 
 
24. Obita, T., Saksena, S., Ghazi-Tabatabai, S., Gill, D. J., Perisic, O., Emr, S. 
D. & Williams, R. L. (2007). Structural basis for selective recognition of 
ESCRT-III by the AAA ATPase Vps4. Nature 449, 735-9. 
 
25. Dimaano, C., Jones, C. B., Hanono, A., Curtiss, M. & Babst, M. (2008). 
Ist1 regulates Vps4 localization and assembly. Mol Biol Cell 19, 465-74. 
 
26. Bajorek, M., Schubert, H. L., McCullough, J., Langelier, C., Eckert, D. M., 
Stubblefield, W. M., Uter, N. T., Myszka, D. G., Hill, C. P. & Sundquist, W. 
I. (2009). Structural basis for ESCRT-III protein autoinhibition. Nat Struct 
Mol Biol 16, 754-62. 
 
27. Muziol, T., Pineda-Molina, E., Ravelli, R. B., Zamborlini, A., Usami, Y., 
Gottlinger, H. & Weissenhorn, W. (2006). Structural basis for budding by 
the ESCRT-III factor CHMP3. Dev Cell 10, 821-30. 
 
28. Xiao, J., Chen, X. W., Davies, B. A., Saltiel, A. R., Katzmann, D. J. & Xu, Z. 
(2009). Structural basis of Ist1 function and Ist1-Did2 interaction in the 
multivesicular body pathway and cytokinesis. Mol Biol Cell 20, 3514-24. 
 
29. Babst, M., Wendland, B., Estepa, E. J. & Emr, S. D. (1998). The Vps4p 
AAA ATPase regulates membrane association of a Vps protein complex 
required for normal endosome function. EMBO J 17, 2982-93. 
 
30. Scott, A., Chung, H. Y., Gonciarz-Swiatek, M., Hill, G. C., Whitby, F. G., 
Gaspar, J., Holton, J. M., Viswanathan, R., Ghaffarian, S., Hill, C. P. & 
Sundquist, W. I. (2005). Structural and mechanistic studies of VPS4 
proteins. EMBO J 24, 3658-69. 
 
31. Gonciarz, M. D., Whitby, F. G., Eckert, D. M., Kieffer, C., Heroux, A., 
Sundquist, W. I. & Hill, C. P. (2008). Biochemical and structural studies of 




32. Hartmann, C., Chami, M., Zachariae, U., de Groot, B. L., Engel, A. & 
Grutter, M. G. (2008). Vacuolar protein sorting: two different functional 
states of the AAA-ATPase Vps4p. J Mol Biol 377, 352-63. 
 
33. Inoue, M., Kamikubo, H., Kataoka, M., Kato, R., Yoshimori, T., Wakatsuki, 
S. & Kawasaki, M. (2008). Nucleotide-dependent conformational changes 
and assembly of the AAA ATPase SKD1/VPS4B. Traffic 9, 2180-9. 
 
34. Xiao, J., Xia, H., Yoshino-Koh, K., Zhou, J. & Xu, Z. (2007). Structural 
characterization of the ATPase reaction cycle of endosomal AAA protein 
Vps4. J Mol Biol 374, 655-70. 
 
35. Landsberg, M. J., Vajjhala, P. R., Rothnagel, R., Munn, A. L. & Hankamer, 
B. (2009). Three-dimensional structure of AAA ATPase Vps4: advancing 
structural insights into the mechanisms of endosomal sorting and 
enveloped virus budding. Structure 17, 427-37. 
 
36. Yu, Z., Gonciarz, M. D., Sundquist, W. I., Hill, C. P. & Jensen, G. J. (2008). 
Cryo-EM structure of dodecameric Vps4p and its 2:1 complex with Vta1p. 
J Mol Biol 377, 364-77. 
 
37. Erzberger, J. P. & Berger, J. M. (2006). Evolutionary relationships and 
structural mechanisms of AAA+ proteins. Annu Rev Biophys Biomol Struct 
35, 93-114. 
 
38. Hanson, P. I. & Whiteheart, S. W. (2005). AAA+ proteins: have engine, will 
work. Nat Rev Mol Cell Biol 6, 519-29. 
 
39. Monroe, N., Han, H., Gonciarz, M. D., Eckert, D. M., Karren, M. A., Whitby, 
F. G., Sundquist, W. I. & Hill, C. P. (2013). The oligomeric state of the 
active Vps4 AAA ATPase. J Mol Biol. 
 
40. Martin, A., Baker, T. A. & Sauer, R. T. (2008). Pore loops of the AAA+ 
ClpX machine grip substrates to drive translocation and unfolding. Nat 
Struct Mol Biol 15, 1147-51. 
 
41. Enemark, E. J. & Joshua-Tor, L. (2006). Mechanism of DNA translocation 
in a replicative hexameric helicase. Nature 442, 270-5. 
 
42. Thomsen, N. D. & Berger, J. M. (2009). Running in reverse: the structural 
basis for translocation polarity in hexameric helicases. Cell 139, 523-34. 
 
43. Lyubimov, A. Y., Strycharska, M. & Berger, J. M. (2011). The nuts and 





44. Roll-Mecak, A. & Vale, R. D. (2008). Structural basis of microtubule 
severing by the hereditary spastic paraplegia protein spastin. Nature 451, 
363-7. 
 
45. Shim, S., Merrill, S. A. & Hanson, P. I. (2008). Novel interactions of 
ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III 
disassembly. Mol Biol Cell 19, 2661-72. 
 
46. Merrill, S. A. & Hanson, P. I. (2010). Activation of human VPS4A by 
ESCRT-III proteins reveals ability of substrates to relieve enzyme 
autoinhibition. J Biol Chem 285, 35428-38. 
 
47. Schlieker, C., Weibezahn, J., Patzelt, H., Tessarz, P., Strub, C., Zeth, K., 
Erbse, A., Schneider-Mergener, J., Chin, J. W., Schultz, P. G., Bukau, B. 
& Mogk, A. (2004). Substrate recognition by the AAA+ chaperone ClpB. 
Nat Struct Mol Biol 11, 607-15. 
 
48. Abrahams, J. P., Leslie, A. G., Lutter, R. & Walker, J. E. (1994). Structure 





CHAPTER 5  
 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary 
        My thesis aimed to understand two aspects of the Vps4 mechanism: how 
the Vps4 oligomer is formed and how Vps4 processes its substrate. Using 
several different biochemical and structural methods, some important progress 
was made. First, we found that Vps4p works as a hexamer in the presence of 
ATP. Second, structures were determined of two Crenarchaeal Vps4 AAA+ 
ATPase cassettes. The similarity between these two structures and the structure 
of eukaryotic Vps4 proteins indicated that the Vps4 3D structure is conserved 
during evolution. Third, the active Vps4 hexamer was found to be asymmetric, 
and the pore loops of the asymmetric hexamer were shown to bind residues of 
helix 5 from the ESCRT-III protein Vps2. The interaction seems to be limited to 
helix 5 due to repulsion between the acidic patch preceding the N-terminus of 
helix 5 of ESCRT-III and the acidic collar on the pore loop 2 of the Vps4 hexamer. 
Fourth, we found that the interaction with Vps2 helix 5 is inhibited by the N-
terminal MIT domain of Vps4, and that this inhibition can be relieved by the MIT-
MIM1 interaction. All of these data are consistent with a two-step model of 
ESCRT-III complex disassembly in which the MIT-MIM interaction recruits the 
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Vps4 hexamer and relieves autoinhibition to facilitate substrate binding by Vps4 
pore loops, followed by translocation of ESCRT-III subunits into the central pore 
of the Vps4 hexamer and concomitant ESCRT-III lattice disassembly. To validate 
and understand the atomic details of this model, more research will be required 
to determine the structure of active Vps4 and understand the mechanism of 
ESCRT-III lattice disassembly. 
 
Future Directions 
Crystallization of Vps4 hexamer 
        Although homology modeling based on the p97 D1 structure has provided a 
useful model for active Vps4 1; 2; 3, a high resolution experimental structure of the 
Vps4 hexamer would be very informational, especially as a complex with an 
ESCRT-III substrate. This structure would provide insight to how Vps4 
disassembles the ESCRT-III complexes and guide future studies. There are 
three different models about the working mechanism of ring-like ATPase: a 
concerted model, a stochastic model, and a rotary model 4. Current structures of 
ring-like ATPases containing the substrate in the central pore support a rotary 
model 5; 6, although both of these structures are ring-like helicases that act on 
nucleic acids: rho helicase from E.coli and E1 helicase from papillomavirus 5; 6. 
There are currently no high resolution structures of AAA+ ATPases bound with 
their corresponding protein/peptide substrate. Our green crystals of Vps4p and 
peptide, although still only diffracting to very low resolution, are attractive targets 
for future optimization because they seem likely to contain a Vps4p hexamer with 
114 
 
a peptide in the central pore (see Chapter 3). The current biochemical data 
suggest that one functional Vps4 hexamer displays multiple ATP-bound states, 
including ATP-bound, ADP-bound, and possibly intermediate and empty states. 
A high resolution structure might support the rotary model of Vps4 function and 
explain how ATP binding and hydrolysis are coordinated with peptide 
binding/processing. 
        I have tried many different strategies to crystallize the Vps4 hexamer. 
However, Vps4 monomers from multiple species have always crystallized in 
spirals. Although the Vps4 hexamer can be obtained in the presence of ADP·AlFx 
and peptide derived from helix 5 of Vps2, this complex has not yet yielded good 
crystals. One approach that could be tried would be to obtain more stable Vps4-
peptide complex for crystallization. Another attractive strategy would be to focus 
on the peptide and ADP·AlFx complex using a variety of truncations on the N-
terminus and surface entropy reduction mutants of Vps4p. 
        One possible approach to finding a tighter-binding peptide would be to 
screen variants of current peptide. For example, alanine screening of peptide C 
may identify variants with improved binding affinity, and a second round of 
mutations on selected residues further increase affinity. Another approach would 
be to sceen peptides from the helix 5 of other ESCRT III proteins. Yet another 
approach could be to truncate the peptide with highest affinity to identify the 
shortest peptide that maintains high affinity, because removing regions that are 




ESCRT-III disassembly by Vps4 
        Several questions need to be addressed in order to understand how binding 
of ESCRT-III helix 5 leads to disassembly.  First, we have to determine the role 
of helix 5 in ESCRT-III assembly. Helix 5 has been suggested to be the 
autoinhibitory because it folds back against the N-terminal helix core in structures 
of monomeric ESCRT-III subunits 7. Although the role of helix 5 in the assembled 
ESCRT-III complexes is not yet established, preliminary cryo-EM studies of 
ESCRT-III tubes assembled in vitro in Dr. Frost’s lab at University of Utah 
suggest that the helix 5 may serve as an intermolecule bridge in the assembled 
ESCRT-III complexes.  If these findings hold-up, they will imply that disrupting 
helix 5 structure may be an effective way to trigger ESCRT-III disassembly by 
disrupting subunit-subunit interactions. 
        A second important question, is how does the Vps4 hexamer process 
different ESCRT-III subunits? There are seven different ESCRT-III and ESCRT-
III-like proteins in yeast and twelve different proteins in human cells. Although the 
3D-structures of different ESCRT-III proteins are predicted to be conserved 8, 
their sequences are not conserved. The C-terminal fragment of several different 
ESCRT-III subunits have been shown to activate the ATPase activity of Vps4 9, 
which indicate Vps4 should be able to process ESCRT-III proteins of different 
sequences. The binding assay between the Vps4 hexamer and different ESCRT-
III subunits will address the question that whether the Vps4 hexamer binds to 
certain sequence selectively. 
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        Third, is the whole protein or only C-terminus of ESCRT-III proteins 
processed by Vps4 hexamer? There is a negatively charged residues patch 
preceding the N-terminus of helix 5 of Vps2. This patch is conserved among 
several other ESCRT-III subunits, and we propose that it functions as a stop sign 
to prevent the N-terminal four helices from being processed by Vps4 hexamer 
based on our fluorescence anisotropy assay (see Chapter 4). This question can 
be explored using ESCRT-III complex disassembly/unfolding assays with a 
variety of ESCRT-III constructs mutations on the negatively charged patch. 
        Fourth, how is the Vps4-ESCRT-III interaction regulated by the MIT domain? 
We have found that the interaction between the Vps4 hexamer and helix 5 of 
Vps2 is autoinhibited by the MIT domain, and that the inhibition can be relieved 
by an MIM1-MIT interaction. The MIT domain may inhibit the proper 
hexamerization of Vps4 or physically block the substrate-binding site. Cryo-EM 
experiment on different wild type Vps4 constructs, including full length Vps4p, 
∆MIT-Vps4p, MIM1-Vps4p, MIM1(L225D)-Vps4p, may help to explore the 
conformational changes induced by the MIT domain and the MIM1-MIT 
interaction. Another possibility would be to use hydrogen exchange experiments 
of MIM1-Vps4p and MIM1(L225D)-Vps4p fusion proteins in the presence of 
ADP·AlFx  to identify a possible interface between the MIT domain and the AAA+ 
ATPase cassette. Cross-linking and mutagenesis experiments might be used to 
confirm this interface if it can be identified by hydrogen exchange.  
        Besides MIM1, some of the ESCRT-III proteins that can also interact with 
the Vps4 MIT domain display a distinctly different MIM2 motif, and the MIM2-MIT 
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interaction has been shown to be important for HIV budding 10. The MIM motif of 
Crenarchaeal ESCRT-III protein interacts with the MIT domain of crenarchaeal 
Vps4 in a similar way as MIM2 11. So, one possibility is to determine if MIT 
domains are autoinhibitory in archaeal Vps4, and if so, determine if inhibition can 
be relieved by an MIM2-MIT.  
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